Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T21:54:37.335Z Has data issue: false hasContentIssue false

Programming by maternal obesity: a pathway to poor cardiometabolic health in the offspring

Published online by Cambridge University Press:  29 July 2022

Isabella Inzani*
Affiliation:
University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Level 4, Addenbrooke's Hospital, Cambridge, Cambridgeshire CB22 0QQ, UK
Susan E. Ozanne
Affiliation:
University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Level 4, Addenbrooke's Hospital, Cambridge, Cambridgeshire CB22 0QQ, UK
*
*Corresponding author: Isabella Inzani, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

There is an ever increasing prevalence of maternal obesity worldwide such that in many populations over half of women enter pregnancy either overweight or obese. This review aims to summarise the impact of maternal obesity on offspring cardiometabolic outcomes. Maternal obesity is associated with increased risk of adverse maternal and pregnancy outcomes. However, beyond this exposure to maternal obesity during development also increases the risk of her offspring developing long-term adverse cardiometabolic outcomes throughout their adult life. Both human studies and those in experimental animal models have shown that maternal obesity can programme increased risk of offspring developing obesity and adipose tissue dysfunction; type 2 diabetes with peripheral insulin resistance and β-cell dysfunction; CVD with impaired cardiac structure and function and hypertension via impaired vascular and kidney function. As female offspring themselves are therefore likely to enter pregnancy with poor cardiometabolic health this can lead to an inter-generational cycle perpetuating the transmission of poor cardiometabolic health across generations. Maternal exercise interventions have the potential to mitigate some of the adverse effects of maternal obesity on offspring health, although further studies into long-term outcomes and how these translate to a clinical context are still required.

Type
Conference on ‘Obesity and the brain’
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press

Worldwide obesity has nearly tripled since 1975 with currently over 1⋅9 billion adults overweight or obese(1). Obesity is a recognised global problem and was declared an epidemic by the WHO in 1997. It therefore represents a significant health and economic burden to societies, and 5 % of deaths worldwide in 2013 were attributed to obesity(Reference Dobbs, Sawers and Thompson2).

Both genetic and environmental factors can affect obesity risk. Overweight and obesity are known risk factors for a large range of non-communicable diseases, including cardiometabolic diseases(1), which are the leading cause of death in men and women globally(3). Cardiometabolic diseases represent a complex cardiovascular and metabolic dysfunction phenotype characterised by insulin resistance and impaired glucose tolerance, dyslipidaemia and adiposity, hypertension and cardiovascular disease (CVD). Cardiometabolic disease is multifactorial, with diet, lifestyle, genetic and epigenetic factors influencing risk(4). Obesity in particular is known to have a significant association with cardiometabolic disease(Reference Dobbs, Sawers and Thompson2).

As the prevalence of obesity increases worldwide this includes women of childbearing age. Over half of women of reproductive age in the UK are currently classed as overweight or obese(Reference Davies5). Obesity during pregnancy is known to have a negative impact on maternal health, pregnancy outcome and the long-term health of her offspring(Reference Poston, Caleyachetty and Cnattingius6,Reference Zambrano, Ibáñez and Martínez-Samayoa7) . This phenomenon by which exposures during early life have impacts on lifelong health is known as the developmental origins of health and disease, following studies of a UK birth cohort, where low birth weights were shown to be associated with increased risk of men developing CVD, hypertension, glucose intolerance, type 2 diabetes and other metabolic diseases in adult life(Reference Barker, Osmond and Golding8Reference Hales, Barker and Clark10). These initial findings have since been replicated in a variety of global cohorts(Reference Eriksson, Forsén and Tuomilehto11Reference Stein, Fall and Kumaran13).

Although initial studies in the developmental origins of health and disease field focused on the detrimental impact of maternal and fetal under-nutrition, in light of the obesity epidemic recent focus has been directed towards the effects of maternal over-nutrition and obesity. Maternal obesity during pregnancy has been associated with a range of poor offspring cardiometabolic outcomes(Reference Eriksson, Sandboge and Salonen14,Reference Reynolds, Allan and Raja15) (Fig. 1). Importantly these effects on offspring health are programmed by the maternal environment independently of the postnatal environment. Adoption studies have shown that despite different postnatal exposures than the biological parent's lifestyle, adopted offspring have a strong association for BMI with that of their biological parents. This could reflect either a genetic or programmed effect of parental obesity on offspring adiposity(Reference Sørensen, Holst and Stunkard16,Reference Sørensen, Holst and Stunkard17) . The effects of genetics v. programmed effects of maternal obesity can be distinguished by studies of siblings born before and after maternal bariatric surgery, thereby controlling for the genetics and lifestyle exposures of the sibling pairs. These studies showed that siblings born after maternal surgery, which resulted in significant maternal weight loss, have reduced prevalence of macrosomia at birth(Reference Smith, Cianflone and Biron18), are less obese(Reference Kral, Biron and Simard19), have lower fasting insulin levels(Reference Guénard, Deshaies and Cianflone20) and improved insulin sensitivity(Reference Smith, Cianflone and Biron18,Reference Guénard, Deshaies and Cianflone20) , lower blood pressure(Reference Guénard, Deshaies and Cianflone20) and improved cardiometabolic markers(Reference Smith, Cianflone and Biron18) in childhood, compared to their sibling born prior to maternal surgery(Reference Kral, Biron and Simard19). Together this evidence suggests that exposure to maternal obesity programmes offspring health by mechanisms that are independent of and additional to genetic and postnatal environmental factors.

Fig. 1. Summary of the programmed effects of maternal obesity on offspring cardiometabolic health in human subjects and animal models. WAT, white adipose tissue.

This review will summarise the evidence from epidemiological studies and animal models for a programmed phenotype (Fig. 1), explore the underlying mechanisms that mediate the programming of adverse offspring cardiometabolic outcomes by maternal obesity, and therefore the opportunities for maternal interventions to prevent transmission of poor cardiometabolic health from mother to child.

Programming of offspring obesity by maternal obesity

Evidence from human studies

Fetal macrosomia is regarded as one of the greatest immediate risks of obese pregnancies, and obese pregnancies have been shown to be associated with a 2–3-fold increase in prevalence of fetal macrosomia at term(Reference Ehrenberg, Mercer and Catalano21). This is associated with increased absolute fetal size and infant fat mass(Reference Sewell, Huston-Presley and Super22,Reference Whitelaw23) . This change in body composition of the offspring continues throughout childhood, adolescence and adulthood, with various studies showing that maternal obesity leads to increased incident of offspring obesity(Reference Schack-Nielsen, Michaelsen and Gamborg24Reference Whitaker, Wright and Pepe30), including alterations in offspring body composition with higher childhood fat mass(Reference Andres, Hull and Shankar26Reference Kaar, Crume and Brinton29,Reference Castillo-Laura, Santos and Quadros31) . Some studies have also suggested that the programming of offspring obesity by maternal obesity may be, in part, sex specific, with male offspring having increased susceptibility to increased adiposity compared to female offspring of obese mothers(Reference Andres, Hull and Shankar26).

Evidence of offspring adiposity from animal models

Animal models are useful tools to help define the mechanisms underlying the programming of increased offspring adiposity by maternal obesity. A variety of model species, including rodents(Reference Liang, Yang and Fu32Reference Chang, Hafner and Varghese40), sheep(Reference Liang, Oest and Prater39,Reference Fensterseifer, Austin and Ford41,Reference Long, Rule and Zhu42) and non-human primates(Reference Lewis, Bertrand and McMahan43), have all recapitulated the observations made in human cohorts that offspring of obese mothers have increased risk of developing obesity compared to offspring of control mothers, with increased offspring body weight and fat mass observed(Reference Menting, Mintjens and van de Beek44).

Sheep models have shown that fetuses of obese ewes have increased fat depots at both mid- and late-gestation compared to fetuses of lean mothers(Reference Fensterseifer, Austin and Ford41,Reference Long, Rule and Zhu42) . This may be in part driven by adipocyte hypertrophy as increased adipocyte cell size has been observed in late-gestation sheep(Reference Long, Rule and Zhu42) fetuses of obese mothers compared to lean controls, with similar findings reported in the mouse(Reference Murabayashi, Sugiyama and Zhang45). Adult offspring of obese rodent dams show a similar phenotype, with increased fat mass driven by a combination of adipocyte hypertrophy and hyperplasia. Rat models have shown male offspring of obese dams have adipocyte hypertrophy compared to controls(Reference Liang, Yang and Fu32Reference Litzenburger, Huber and Dinger35). However reports of adipocyte hyperplasia are more conflicted with some showing evidence of increased adipocyte hyperplasia(Reference Lecoutre, Deracinois and Laborie34), while others have shown it to be impaired(Reference Liang, Yang and Fu32). Furthermore, while increased white adipose tissue mass has been seen in offspring of both sexes, the mechanisms for this expansion may be sexually dimorphic. Rat models of maternal obesity showing increased adipocyte cell size in males, did not see a similar increase in female offspring adipocytes(Reference Lecoutre, Deracinois and Laborie34,Reference Litzenburger, Huber and Dinger35) . However, conversely, in a baboon model of pre-weaning over-nutrition, offspring adipocyte hypertrophy was seen in only female offspring at 5 years of age(Reference Lewis, Bertrand and McMahan43).

There is also evidence of altered adipocyte metabolism and increased fatty acid accumulation in fetuses of obese pregnancies, with increased expression of fatty acid and glucose transporters and of fatty acid biosynthesis enzymes in fetal sheep adipose tissue in response to maternal obesity(Reference Long, Rule and Zhu42). This is accompanied by altered expression of genes which regulate adipogenesis, lipogenesis and the synthesis of adipokines(Reference Muhlhausler, Duffield and McMillen46), leading to increased lamb fat mass observed in early postnatal life(Reference Muhlhausler, Duffield and McMillen46). Increased fetal insulin concentration and the development of fetal insulin resistance may also contribute to increased fetal fat accretion, with fetuses of mice fed with a high-fat diet before and throughout pregnancy showing evidence of adipose tissue insulin resistance(Reference Murabayashi, Sugiyama and Zhang45). Furthermore, increased inflammation of the subcutaneous adipose tissue has been reported in fetal mice of high-fat diet-fed dams(Reference Murabayashi, Sugiyama and Zhang45). Similarly postnatally, a rat model of maternal diet-induced obesity showed dysregulated expression of adipogenic and lipogenic genes at both 2 weeks and 2 months of age in offspring of obese dams compared to controls(Reference Sen and Simmons47). Adult mouse offspring also show evidence of increased adipose tissue inflammation(Reference Chang, Hafner and Varghese40,Reference Bae-Gartz, Janoschek and Kloppe48) . This may be sex specific as mouse offspring of obese dams, when themselves are exposed to a high-fat diet challenge in adulthood, showed increased visceral adipose tissue inflammation in male, but not female, offspring(Reference Chang, Hafner and Varghese40). Altered miRNA expression is one potential mechanism for programming of adipose tissue inflammation, with one mouse model of maternal diet-induced obesity showing reduced expression of miR-706 (known to regulate inflammatory protein expression) in adipose tissue from male offspring(Reference Alfaradhi, Kusinski and Fernandez-Twinn49).

Evidence of offspring hyperphagia from animal models

Maternal obesity has also been shown to programme offspring obesity via offspring hyperphagia and thus increased energy intake. Offspring hyperphagia has been observed in several different rodent models of maternal obesity, in both male and female offspring(Reference Chang, Gaysinskaya and Karatayev50Reference Glavas, Kirigiti and Xiao53). It is thought that this hyperphagic phenotype may be driven by altered development and function of the hypothalamic circuits which regulate appetite and energy expenditure. Both leptin and insulin, which are altered in the maternal circulation during obesity, are known to affect neural development and have therefore both been implicated as factors mediating the programming effects of hypothalamic development.

The timing of the rodent neonatal leptin surge is a critical window for hypothalamic neuronal circuitry development and maturation. Neonatal rats born from obese mothers have an enhanced and prolonged postnatal leptin surge(Reference Kirk, Samuelsson and Argenton52). In contrast in lambs, maternal obesity has been shown to result in a reduced neonatal leptin surge(Reference Long, Ford and Nathanielsz54). However, despite the reduced neonatal leptin surge in lambs exposed to maternal obesity in utero, postnatally they have increased subcutaneous adipose tissue fat mass and adipose tissue leptin gene expression compared to offspring of controls(Reference Muhlhausler, Duffield and McMillen55). As the hypothalamus requires the correct levels and timings of exposure in order to correctly develop, any perturbations leading to either under- or over-exposure to leptin during these critical developmental windows can have negative impacts. Furthermore, rat fetuses of high-fat diet-fed dams have hypothalamic leptin resistance, with reduced expression of downstream leptin signalling components despite elevated plasma leptin levels compared to fetuses from healthy pregnancies, which is accompanied by increased mRNA expression of the orexigenic neuropeptides neuropeptide Y and agouti-related protein(Reference Gupta, Srinivasan and Thamadilok56). This leptin resistance persists postnatally in adult rodent offspring exposed to either gestational or lactational over-nutrition(Reference Kirk, Samuelsson and Argenton52,Reference Glavas, Kirigiti and Xiao53) , and leptin infusion into these offspring fails to reduced food intake in offspring of both sexes(Reference Kirk, Samuelsson and Argenton52).

In addition to leptin, neonatal insulin signalling also plays an important role in regulation of hypothalamic development. Maternal obesity in mice has been shown to result in impaired offspring proopiomelanocortin neurone projection development, which was corrected by inhibition of insulin signalling in proopiomelanocortin neurones(Reference Vogt, Paeger and Hess57). The fetal hypothalamus also develops insulin resistance in a maternal obesogenic environment, and both mid- and late-gestation rodent fetuses of obese dams have reduced downstream insulin signalling despite increased serum insulin levels(Reference Gupta, Srinivasan and Thamadilok56,Reference Dearden, Buller and Furigo58) . The inability of these offspring to appropriately respond to satiety signals may therefore contribute to the programming of offspring hyperphagia, and thus the risk of developing increased adiposity and obesity.

Overall, maternal obesity can lead to increased offspring adiposity accompanied by altered adipose tissue metabolism, inflammation and insulin resistance, as well as dysregulation of appetite regulation in the hypothalamus, thus predisposing them to obesity in later life (Fig. 1).

Programming of offspring type 2 diabetes by maternal obesity

Evidence from human studies

Maternal obesity is known to result in increased risk of offspring developing type 2 diabetes, characterised by insulin resistance and β-cell dysfunction(Reference Galicia-Garcia, Benito-Vicente and Jebari59). Studies in human subjects have shown that maternal obesity leads to increased fetal insulin resistance compared to lean controls(Reference Catalano, Presley and Minium60). This insulin resistance persists into childhood, where maternal obesity is associated with increased risk of insulin resistance(Reference Kaar, Crume and Brinton29,Reference Maftei, Whitrow and Davies61) , developing type 2 diabetes(Reference Dabelea, Mayer-Davis and Lamichhane62) and the metabolic syndrome(Reference Boney, Verma and Tucker63). This association continues in adulthood, with maternal obesity increasing the risk of insulin resistance(Reference Hochner, Friedlander and Calderon-Margalit64) and type 2 diabetes(Reference Eriksson, Sandboge and Salonen14,Reference Fall, Stein and Kumaran65,Reference Lahti-Pulkkinen, Bhattacharya and Wild66) .

Evidence of offspring insulin resistance from animal models

Consistent with human studies, animal models have also shown that maternal obesity results in the development of altered offspring insulin sensitivity. Although the exact offspring phenotype varies depending on the species and model of maternal over-nutrition/obesity, the programming of offspring metabolic dysfunction is consistently observed. Indeed, several rodent models have shown that maternal over-nutrition results in offspring hyperinsulinaemia(Reference Rajia, Chen and Morris67Reference Samuelsson, Matthenws and Argenton73), glucose intolerance(Reference Desai, Jellyman and Han38,Reference Rajia, Chen and Morris67,Reference Fernandez-Twinn, Alfaradhi and Martin-Gronert74) and insulin resistance(Reference Desai, Jellyman and Han38,Reference Rajia, Chen and Morris67Reference Zambrano, Sosa-Larios and Calzada69,Reference Shankar, Harrell and Liu75Reference Graus-Nunes, Dalla Corte Frantz and Lannes77) . Studies in Agouti yellow mice, a model of normoglycemic obesity, have highlighted that maternal obesity alone, in the absence of maternal hyperinsulinaemia, is sufficient to impair offspring insulin signalling and glucose tolerance(Reference Han, Xu and Epstein78,Reference Li, Young and Maloney79) . While many early studies focused mainly on the phenotype of male offspring(Reference Rajia, Chen and Morris67,Reference Buckley, Keserü and Briody70,Reference Samuelsson, Matthenws and Argenton73,Reference Shankar, Harrell and Liu75) , studies investigating both offspring sexes have revealed some sex-specific differences in the programming of offspring metabolic dysfunction by maternal obesity. However, whether males(Reference Chang, Hafner and Varghese40,Reference Li, Young and Maloney79,Reference Yokomizo, Hasegawa and Ishitobi80) or females(Reference Han, Xu and Epstein78,Reference Akhaphong, Gregg and Kumusoglu81,Reference Dearden and Balthasar82) are more susceptible to the programming of insulin resistance and glucose intolerance by maternal obesity varies between studies.

Skeletal muscle is a key insulin responsive tissue, with insulin promoting glucose uptake into muscle cells. Thus, impairment of the skeletal muscle response to insulin can contribute to the pathogenesis of type 2 diabetes. In an ovine model of diet-induced obesity, late-gestation fetuses were shown to have impaired skeletal muscle insulin action with decreased Akt phosphorylation despite higher circulating levels of insulin compared to fetuses of control ewes(Reference Yan, Zhu and Xu83). However, conversely, in mice, high-fat diet feeding prior to conception resulted in increased fetal and neonatal activation of insulin signalling in skeletal muscle, compared to offspring of lean control mothers(Reference Qiao, Wattez and Lim84). However, in adult offspring, maternal obesity has been shown consistently to cause skeletal muscle insulin resistance(Reference Yan, Huang and Zhao85), with disrupted expression of key downstream insulin signalling molecules seen in both sheep(Reference Nicholas, Morrison and Rattanatray86) and rodent(Reference de Fante, Simino and Reginato87,Reference Shelley, Martin-Gronert and Rowlerson88) models of maternal obesity. Similarly, rat offspring of cafeteria diet-fed dams had altered skeletal muscle metabolism at weaning indicative of insulin resistance(Reference Bayol, Simbi and Stickland89).

The liver also plays an important role in regulation of glucose homoeostasis, with insulin signalling acting to promote hepatic storage of glucose as glycogen. Similarly to skeletal muscle, maternal obesity influences insulin signalling in the fetal liver, with dysregulated expression of miRNAs associated with insulin signalling, accompanied by increased liver lipid accumulation seen in the late-gestation primate fetal liver(Reference Puppala, Li and Glenn90), and increased activation of fetal hepatic insulin signalling in mice(Reference Qiao, Wattez and Lim84). A similar phenotype is also seen in the adult offspring liver in rats(Reference Buckley, Keserü and Briody70), mice(Reference de Fante, Simino and Reginato87,Reference Martin-Gronert, Fernandez-Twinn and Poston91) and sheep(Reference Nicholas, Rattanatray and MacLaughlin92). For example, maternal obesity in sheep alters the expression of key insulin signalling molecules and factors which regulate gluconeogenesis in the male and female offspring liver(Reference Nicholas, Rattanatray and MacLaughlin92,Reference Rattanatray, Muhlhausler and Nicholas93) . Similar to the primate fetus, this may be due to dysregulated expression of miRNAs related to insulin signalling(Reference Nicholas, Rattanatray and MacLaughlin92). In rodents some of these effects have been shown to be sex specific as transcriptomic analysis of livers of offspring born to obese dams has shown a male-specific dysregulation of pathways involved in insulin signalling and glycolysis/gluconeogenesis(Reference Lomas-Soria, Reyes-Castro and Rodríguez-González94).

Adipose tissue is also sensitive to insulin action, where insulin promotes adipocyte glucose uptake and inhibits lipolysis. Several studies in mouse models have shown that maternal obesity impairs offspring white adipose tissue insulin signalling(Reference Alfaradhi, Fernandez-Twinn and Martin-Gronert72,Reference Fernandez-Twinn, Alfaradhi and Martin-Gronert74,Reference de Fante, Simino and Reginato87) , and similar to the liver, this may be associated with altered regulatory miRNA expression in offspring adipose tissue(Reference Fernandez-Twinn, Alfaradhi and Martin-Gronert74).

Evidence of offspring pancreatic β-cell dysfunction from animal models

In addition to systemic insulin resistance, insufficient insulin production, processing and release from pancreatic β-cells is also characteristic of type 2 diabetes. In the initial stages of type 2 diabetes, when peripheral tissues become insulin resistant, the pancreas can attempt to compensate, increasing β-cell number, size and insulin production. However, as disease progresses β-cell exhaustion can lead to reduced function and cell death. Animal models have shown significant evidence of offspring β-cell dysfunction in response to exposure to maternal obesity.

In the fetus, maternal obesity in sheep results in increased relative pancreatic weight and β-cell number and proliferation at mid-gestation(Reference Ford, Zhang and Zhu95), but reduced pancreatic weight and β-cell numbers in late-gestation(Reference Zhang, Long and Hein96), with increased β-cell apoptosis and a resultant decrease in blood insulin levels and increase in glucose levels at birth(Reference Zhang, Long and Hein96). Similarly, maternal obesity has been shown to significantly reduce β-cell mass in neonatal mice(Reference Bringhenti, Moraes-Teixeira and Cunha97) and rats(Reference Cerf, Williams and Nkomo98), resulting in neonatal hyperglycaemia(Reference Cerf, Williams and Nkomo98). However, in contrast, another model of mice fed with a high-fat diet prior to pregnancy resulted in increased fetal pancreatic β-cell mass and thus elevated fetal blood insulin levels and reduced glucose concentrations, compared to control fetuses(Reference Qiao, Wattez and Lim84). Regardless of the exact phenotype, if these alterations to fetal pancreatic growth and function are not corrected in later life it can lead to a predisposition for offspring glucose intolerance and thus increased risk of developing type 2 diabetes.

In rodents, postnatal offspring of dams fed with a high-fat diet during gestation show progressive β-cell dysfunction with increased β-cell hypertrophy(Reference Graus-Nunes, Dalla Corte Frantz and Lannes77,Reference Cerf and Louw99) and proliferation(Reference Bringhenti, Moraes-Teixeira and Cunha97,Reference Cerf and Louw99,Reference Zheng, Zhang and Wang100) seen in the young adult offspring of obese dams compared to controls, accompanied by increased β-cell insulin content(Reference Zheng, Zhang and Wang100), and enhanced glucose-stimulated insulin release(Reference Bringhenti, Moraes-Teixeira and Cunha97), characteristic of the initial β-cell response to increased peripheral insulin resistance. However, as insulin resistance progresses, loss of β-cell function leads to decreased pancreatic insulin content(Reference Taylor, McConnell and Khan68,Reference Samuelsson, Matthenws and Argenton73) , impaired insulin secretion from pancreatic islets(Reference Taylor, McConnell and Khan68) and offspring hypoinsulinaemia(Reference Cerf, Muller and Toit101).

Some studies suggest that male mouse offspring may be more vulnerable to the programming of poor β-cell development(Reference Yokomizo, Inoguchi and Sonoda71), function(Reference Casasnovas, Damron and Jarrell102), survival and oxidative stress(Reference Yokomizo, Inoguchi and Sonoda71), with the female offspring pancreas being more protected(Reference Yokomizo, Inoguchi and Sonoda71). In fact the female offspring pancreas may be primed by exposure to maternal obesity to be better able to cope with exposure to over-nutrition in postnatal life(Reference Nicholas, Nagao and Kusinski103). However, conflicting studies have reported a more severe phenotype in females with increased pancreatic dysfunction(Reference Han, Xu and Epstein78), disrupted islet metabolism(Reference Han, Xu and Epstein78) and significantly reduced glucose-stimulated insulin release(Reference Han, Xu and Epstein78) specifically in female mouse offspring of obese mothers compared to offspring of controls.

This evidence suggests that exposure to a maternal obesogenic environment has long-term effects on β-cell function and peripheral organ insulin resistance, contributing to the increased risk of offspring developing insulin resistance and type 2 diabetes (Fig. 1).

Programming of offspring cardiac dysfunction by maternal obesity

Evidence from human studies

Maternal obesity in human subjects is known to be associated with increased risk of congenital heart disease(Reference Liu, Ding and Yang104), however relatively little research has been carried out to study the effect of maternal obesity on other aspects of the fetal heart. At mid-gestation the effects of maternal obesity appear relatively small with evidence of reduced left and right ventricular strain suggesting impaired contractile function, but no observed effects on fetal cardiac dimensions, heart rate, blood flow velocities or standard echocardiographic parameters of systolic and diastolic function(Reference Ingul, Lorås and Tegnander105,Reference Kulkarni, Li and Craft106) . However, later in gestation there is persistence of reduced ventricular strain, accompanied by the development of impaired diastolic function, although no clear changes in cardiac systolic function are observed(Reference Ingul, Lorås and Tegnander105,Reference Ece, Uner and Balli107) . Additionally, there are late-gestational changes in cardiac morphology in fetuses exposed to maternal obesity with increased ventricular wall widths and reduced chamber widths(Reference Ingul, Lorås and Tegnander105,Reference Mat Husin, Schleger and Bauer108) . However, there are still no observed differences in heart rate or cardiac blood flow in human fetuses of obese mothers in the third trimester, suggesting that maternal obesity does not cause overt fetal cardiac dysfunction despite the observed diastolic impairment(Reference Ingul, Lorås and Tegnander105,Reference Ece, Uner and Balli107) .

In adulthood, several studies have shown a significant association between maternal BMI and increased risk of CVD in her children(Reference Eriksson, Sandboge and Salonen14,Reference Reynolds, Allan and Raja15,Reference Forsén, Eriksson and Tuomilehto109Reference Labayen, Ruiz and Ortega113) . One early study in a population of 3302 Finnish men showed that a higher maternal BMI was associated with increased risk of death due to coronary heart disease in her adult offspring(Reference Forsén, Eriksson and Tuomilehto109). These results were later supported by similar results seen in a larger Scottish cohort of 37 709 men and women, where offspring of obese mothers were shown to have increased risk of hospital admissions for a cardiovascular event aged 31–64 years(Reference Reynolds, Allan and Raja15). Data from men and women in the Helsinki Birth Cohort have also shown an association between maternal BMI and increased risk of offspring coronary heart disease and stroke(Reference Eriksson, Sandboge and Salonen14), while offspring from the 1958 British birth cohort have shown that parental BMI is positively associated with increased CVD risk factors in offspring aged 44–45 years(Reference Cooper, Pinto Pereira and Power111). Furthermore, a more recent large Swedish cohort has also shown increased risk of childhood and young adult CVD with increasing maternal BMI(Reference Razaz, Villamor and Muraca110). Importantly, this association was maintained in a sibling-controlled analysis, supporting a more causal relationship between maternal BMI and offspring CVD, after controlling for shared sibling environmental and genetic factors(Reference Razaz, Villamor and Muraca110).

Human studies looking more specifically at offspring cardiac structure and function in childhood have shown that high maternal BMI was associated with increased left ventricular mass and hypertrophy in 6 year old offspring(Reference Toemen, Gishti and van Osch-Gevers114), but not relative wall thickness(Reference Toemen, Gishti and van Osch-Gevers114), fractional shortening(Reference Toemen, Gishti and van Osch-Gevers114) or other indices of left ventricular systolic or diastolic function as assessed by echocardiography(Reference Litwin, Sundholm and Rönö112). Overall, these studies suggest that, while maternal obesity does not programme overt cardiac dysfunction in early childhood, it does increase the risk of offspring developing CVD in adulthood.

Evidence of offspring cardiac dysfunction from animal models

The effects of maternal obesity on the offspring heart at the cellular and molecular levels have been investigated further using animal models. While a range of species and maternal obesity models have been used, similar cardiac phenotypes are observed across species. Despite inconsistencies in the effect of maternal obesity to increase fetal heart weights, in mid-gestation fetal sheep(Reference Kandadi, Hua and Zhu115Reference George, Uthlaut and Long118) and neonatal rats(Reference Zhang, Cao and Tan119Reference Xue, Chen and Zhang121), although not in late-gestation sheep(Reference Kandadi, Hua and Zhu115,Reference Fan, Turdi and Ford116) or baboons(Reference Maloyan, Muralimanoharan and Huffman122), there is consistent evidence that maternal obesity leads to offspring cardiomyocyte hypertrophy. Indeed, increased cell size and expression of hypertrophy markers have been consistently reported in the hearts of fetal sheep(Reference Kandadi, Hua and Zhu115,Reference Wang, Zhu and Sun123) and neonatal minipigs(Reference Guzzardi, Liistro and Gargani124) and rodents(Reference Zhang, Cao and Tan119Reference Xue, Chen and Zhang121). In adulthood, mouse offspring of obese mothers have also been shown to exhibit increased left ventricular mass and area(Reference Loche, Blackmore and Carpenter125Reference Blackmore, Niu and Fernandez-Twinn127), with increased cardiomyocyte cell size in 3-(Reference Blackmore, Niu and Fernandez-Twinn127) and 8-(Reference Loche, Blackmore and Carpenter125Reference Beeson, Blackmore and Carr128)week-old male offspring, although this was a transient phenotype which was lost by 12 weeks of age(Reference Blackmore, Niu and Fernandez-Twinn127). This increased cardiomyocyte cell size was accompanied by re-expression of fetal genes and miRNAs associated with pathological hypertrophy in young adult male mouse offspring of obese mothers(Reference Loche, Blackmore and Carpenter125Reference Beeson, Blackmore and Carr128). One potential mechanism for the programming of this pathological remodelling is hyperinsulinaemia-induced overactivation of cardiac insulin signalling. Consistent with this hypothesis, in a mouse model of maternal diet-induced obesity, although insulin receptor levels were reduced in the hearts of offspring of obese dams, the downstream signalling components were upregulated(Reference Fernandez-Twinn, Blackmore and Siggens126).

Changes in fetal cardiomyocyte growth have been reported to be accompanied by changes in cardiomyocyte structure with irregular orientation of myofibrils in mid- and late-gestational fetal sheep(Reference Kandadi, Hua and Zhu115,Reference Fan, Turdi and Ford116,Reference Wang, Zhu and Sun123) and rats(Reference Mdaki, Larsen and Wachal120,Reference Xue, Chen and Zhang121) exposed to maternal obesity, in parallel with altered expression of contractile proteins which could affect cardiac ionotropic function(Reference Kandadi, Hua and Zhu115,Reference Fan, Turdi and Ford116,Reference Wang, Zhu and Sun123) . Indeed, cardiomyocytes isolated from fetuses of obese ewes showed impaired contractility and calcium handling(Reference Wang, Zhu and Sun123). Furthermore, hearts isolated from late-gestational fetal sheep showed impaired cardiac function as they were unable to maintain increased contractile performance when subjected to a higher workload, although baseline cardiac function was unaffected by maternal obesity(Reference Ingul, Lorås and Tegnander105,Reference Ece, Uner and Balli107,Reference Wang, Ma and Tong129) . Similarly, neonatal rats(Reference Mdaki, Larsen and Wachal120) and pigs(Reference Guzzardi, Liistro and Gargani124) when exposed to maternal obesity and diabetes in utero showed cardiac systolic and diastolic in vivo dysfunction.

Impaired cardiac contractility programmed by maternal obesity persists into adulthood, with a mouse model of diet-induced obesity showing impaired in vivo systolic and diastolic function, as assessed by echocardiography in male offspring of obese dams compared to controls at 8 weeks of age(Reference Loche, Blackmore and Carpenter125,Reference Beeson, Blackmore and Carr128) , and in ex vivo Langendorff preparations at 12 weeks of age(Reference Blackmore, Niu and Fernandez-Twinn127). Furthermore, administration of parasympathetic and sympathetic agents to these heart preparations showed a blunted response to parasympathetic stimulation, but enhanced contractile response to sympathetic stimulation, indicative of sympathetic dominance, a marker of heart failure, in the hearts of offspring of obese dams(Reference Blackmore, Niu and Fernandez-Twinn127).

Further changes in the fetal heart in response to maternal obesity include increased lipid droplet accumulation in fetal sheep(Reference Kandadi, Hua and Zhu115) and neonatal rat(Reference Mdaki, Larsen and Wachal120), and increased fibrosis in fetal sheep and neonatal mouse(Reference Zhang, Cao and Tan119) which may increase cardiac stiffness, potentially leading to impaired cardiac function(Reference Fan, Turdi and Ford116,Reference Maloyan, Muralimanoharan and Huffman122,Reference Huang, Yan and Zhao130) . Increased cardiac fibrosis was also seen in 8-week-old mouse offspring of obese dams, when challenged with a high-fat diet in postnatal life(Reference Loche, Blackmore and Carpenter125).

There is also increased cardiac inflammation seen in the hearts of fetal sheep exposed to maternal obesity(Reference Kandadi, Hua and Zhu115), as well as attenuated sensitivity to insulin(Reference Wang, Ma and Tong129), and reduced expression of the cardioprotective AMP-activated protein kinase signalling pathway, which may be involved in metabolic regulation and substrate metabolism(Reference Wang, Ma and Tong129). Altered energy metabolism was also seen in the hearts of neonatal pigs and fetal mice born to high-fat diet-fed mothers suggestive of changes in cardiomyocyte energy metabolism shifting from glycolytic towards oxidative cardiac metabolism(Reference Guzzardi, Liistro and Gargani124,Reference Pantaleão, Inzani and Furse131) .

Maternal obesity in rodents has been shown to result in impaired offspring mitochondrial structure and function in both early and adult life(Reference Mdaki, Larsen and Wachal120,Reference Xue, Chen and Zhang121,Reference Larsen, Sabey and Knutson132,Reference Ferey, Boudoures and Reid133) , which may lead to impaired mitochondrial function, cellular metabolism and increased reactive oxygen species production. Indeed, neonatal rat cardiomyocytes of obese dams had lower basal oxygen consumption(Reference Mdaki, Larsen and Wachal120), and increased cardiac oxidative stress(Reference Zhang, Cao and Tan119,Reference Mdaki, Larsen and Wachal120,Reference Lin, Han and Fang134) and reactive oxygen species production(Reference Zhang, Cao and Tan119). Increased oxidative stress and reactive oxygen species production in the heart has also been seen in adult male offspring of obese mouse dams(Reference Fernandez-Twinn, Blackmore and Siggens126), although this result has not been recapitulated in every study(Reference Loche, Blackmore and Carpenter125).

Importantly, many of these differences in cardiac structure and function have been observed in the absence of a difference in body weight between the offspring of obese and lean dams, and thus show that in rodents maternal obesity is able to programme cardiac function independent of offspring obesity(Reference Fernandez-Twinn, Blackmore and Siggens126,Reference Blackmore, Niu and Fernandez-Twinn127) . Potential mechanisms for the programming of altered cardiac function include epigenetic alterations. Rat offspring exposed to maternal high-fat diet have differential histone modifications linked to altered regulation of genes involved in metabolic stress and cardiac dysfunction(Reference Upadhyaya, Larsen and Barwari135), and altered histone marks and DNA methylation resulting in the de-repression of pro-fibrotic and pro-hypertrophic genes(Reference Blin, Liand and Mauduit136). Furthermore, dysregulation of miRNA expression may also play a role, and analysis of miRNA expression in the hearts of fetal baboons found altered expression of miRNAs associated with adult CVD, cardiac hypertrophy, enhanced fibrosis, growth, proliferation and cellular development(Reference Maloyan, Muralimanoharan and Huffman122).

Exposure to maternal obesity also increases susceptibility of the offspring heart to damage from subsequent challenges. This includes a more severe cardiac phenotype when offspring of obese mothers are exposed to high-fat diet feeding in adult life with enhanced cardiac contractile dysfunction, cardiac hypertrophy, fibrosis, lipid accumulation, inflammation, reactive oxygen species accumulation, mitochondrial dysfunction and apoptosis seen in both rodent and sheep models(Reference Turdi, Ge and Hu137,Reference Ghnenis, Odhiambo and McCormick138) . Another postnatal stress via transverse aortic constriction in rats also resulted in exacerbated cardiac dysfunction if offspring were exposed to a maternal high fructose diet(Reference Leu, Wu and Lee139). Programming by maternal obesity also increases susceptibility to ischaemia-reperfusion injury in offspring of obese dams in both rats and mice(Reference Xue, Chen and Li140,Reference Calvert, Lefer and Gundewar141) . While some phenotypes appear shared by both male and female offspring(Reference Zhang, Cao and Tan119,Reference Ferey, Boudoures and Reid133) , there is inconsistent evidence in both rat and mouse models that some programming of cardiac dysfunction by maternal obesity shows sexual dimorphism, with male-specific cardiac hypertrophy(Reference Xue, Chen and Li140) and susceptibility to ischaemia-reperfusion injury(Reference Xue, Chen and Li140,Reference Calvert, Lefer and Gundewar141) in offspring of obese dams, but female-specific impairment of systolic and diastolic function in offspring of obese mice(Reference Ferey, Boudoures and Reid133).

Together this shows that maternal obesity effects offspring cardiac development and function, thus predisposing offspring to increased risk of developing CVD (Fig. 1).

Programming of offspring hypertension by maternal obesity

Evidence of offspring hypertension from human studies

Blood pressure is primarily influenced by a combination of cardiac output and systemic vascular resistance. Cardiac output in turn is affected by blood volume, cardiac contractility, heart rate and afterload, while systemic vascular resistance can be affected by increased vasoconstriction and arterial stiffness. Cardiac function (discussed earlier), kidney function, vascular responsiveness to vasoactive signals and vascular compliance therefore all play a role in the regulation of blood pressure.

A variety of global cohorts have shown an association between maternal obesity during pregnancy and increased risk of hypertension with raised blood pressure in her children at various ages from early childhood to adulthood(Reference Gaillard, Steegers and Duijts28,Reference Hochner, Friedlander and Calderon-Margalit64,Reference Cox, Luyten and Dockx142Reference Laor, Stevenson and Shemer148) . Some studies and meta-analyses have reported that observations of increased childhood blood pressure are independent of childhood BMI(Reference Gaillard, Steegers and Duijts28,Reference Cox, Luyten and Dockx142,Reference Eitmann, Mátrai and Németh149) . However, another systematic review has suggested hypertension may be at least partially programmed secondary to the programming of increased adiposity in offspring of obese mothers(Reference Ludwig-Walz, Schmidt and Günther150). Controlling for childhood BMI was also shown to significantly decrease the association between maternal pre-pregnancy BMI and offspring hypertension in childhood(Reference Gaillard, Steegers and Duijts28,Reference Gademan, van Eijsden and Roseboom143) and adulthood(Reference Cooper, Pinto Pereira and Power111,Reference Brunton, Dufault and Dart151) , although a significant effect of maternal obesity did remain, indicating both direct and indirect programming mechanisms may be involved. One potential mechanism by which maternal obesity programmes increased offspring hypertension is by alterations in vascular function. This is supported by observations that maternal obesity is associated with increased carotid intima-media thickness(Reference Sundholm, Litwin and Rönö152), and increased retinal vessel tortuosity(Reference Cox, Luyten and Dockx142), a non-invasive assessment of alterations in the microcirculation, in her children.

Evidence of offspring hypertension from animal models

Animal models of maternal obesity have shown similar phenotypes to those seen in clinical studies. In particular, many different rodent models have shown an increased risk of hypertension in adult offspring of obese mothers compared to lean controls(Reference Desai, Jellyman and Han38,Reference Samuelsson, Matthenws and Argenton73,Reference Loche, Blackmore and Carpenter125,Reference Guberman, Jellyman and Han153Reference Torrens, Ethirajan and Bruce157) . In a rat model of maternal diet-induced obesity, offspring hypertension was observed in juvenile offspring, prior to the development of offspring adiposity, providing evidence for the direct programming of offspring hypertension by maternal obesity, independent of offspring obesity(Reference Samuelsson, Morris and Igosheva156). Furthermore, mouse models have shown the effects of maternal obesity and offspring postnatal high-fat diet to increase young adult offspring blood pressure to be additive(Reference Loche, Blackmore and Carpenter125). Thus, maternal obesity and offspring obesity are able to independently promote hypertension.

The increase in offspring hypertension in response to maternal obesity may be, at least in part, due to the programming of altered vascular structure and function. Rat offspring of dams fed with a high-fat diet during pregnancy and lactation show alterations in aortic structure at 6 months of age with reduced aortic endothelial cell volume and smooth muscle cell number(Reference Armitage, Lakasing and Taylor158). Structural changes in the offspring abdominal aorta have also been seen in non-human primate offspring of high-fat diet-fed mothers with increased intima media thickness compared to offspring of control mothers(Reference Fan, Lindsley and Comstock159). Rat offspring of obese dams also have abnormal aortic fatty acid composition(Reference Ghosh, Bitsanis and Ghebremeskel160), and increased aortic stiffness(Reference Armitage, Lakasing and Taylor158). Furthermore, rodent offspring of high-fat diet-fed mothers have impaired endothelial-dependent vasodilation of the aorta(Reference Armitage, Lakasing and Taylor158), femoral(Reference Torrens, Ethirajan and Bruce157,Reference Ghosh, Bitsanis and Ghebremeskel160,Reference Koukkou, Ghosh and Lowy161) and mesenteric(Reference Samuelsson, Matthenws and Argenton73,Reference Taylor, Khan and Hanson162Reference Khan, Taylor and Dekou164) arteries, as well as an enhanced femoral vasoconstrictor response to noradrenaline(Reference Koukkou, Ghosh and Lowy161), and reduced mesenteric vasoconstrictor response to phenylephrine(Reference Gray, Vickers and Segovia163). This may, at least in part, be due to impaired nitric oxide bioavailability(Reference Torrens, Ethirajan and Bruce157) and thus impaired nitric oxide-dependent endothelial function(Reference Gray, Vickers and Segovia163).

Studies of maternal diet-induced obesity in rats have suggested that the hypertension observed in offspring of obese dams has a sympathetic origin, as analysis of heart rate viability indicated an increase in the sympathetic component of blood pressure regulation, while β-adrenergic blockage was shown to inhibit the hypertensive phenotype(Reference Samuelsson, Morris and Igosheva156). There was also altered responses to phenylephrine or sodium nitroprusside indicative of reduced baroreflex sensitivity(Reference Samuelsson, Morris and Igosheva156). Similarly, in mouse offspring of obese dams, observations of increased blood pressure without a difference in heart rate suggest a resetting of the arterial baroreflex to allow an elevated resting arterial blood pressure(Reference Loche, Blackmore and Carpenter125). It is possible that programming of adult offspring hypertension is, at least in part, due to fetal and neonatal hyperleptinaemia affecting the development of hypothalamic neural circuits involved in blood pressure regulation(Reference Taylor, Samuelsson and Poston165). Leptin is known to affect the development and function of neural circuits involved in the autonomic nervous system regulation of blood pressure in mice(Reference Bouret, Draper and Simerly166). Furthermore, treatment of control-fed rat pups with exogenous leptin, mimicking the neonatal hyperleptinaemia seen in offspring of obese dams, increased offspring systolic blood pressure at 1 month of age with evidence of heightened sympathetic tone compared to saline-treated control offspring(Reference Samuelsson, Clark and Rudyk167).

Evidence of offspring kidney dysfunction from human studies and animal models

With regards to kidney function, human studies have shown maternal obesity to be associated with congenital abnormalities of the kidney and urinary tract(Reference Macumber, Schwartz and Leca168,Reference Hsu, Yamamoto and Henry169) and reduced late-gestational fetal kidney volume relative to fetal body weight(Reference Lee, Lumbers and Oldmeadow170). As kidney volume is suggested as an approximate measure of renal nephron number(Reference Luyckx and Brenner171), maternal adiposity may be associated with reduced fetal nephron count, which can potentially lead to nephron hyperfiltration in order to maintain renal function, and thus progressive kidney damage and the development of hypertension in later life(Reference Brenner and Chertow172). Consistent with these observations, maternal obesity has been associated with increased risk of offspring developing childhood chronic kidney disease in a US-based cohort(Reference Hsu, Yamamoto and Henry169).

In contrast, a study in rats has shown that exposure to maternal obesity in the late-gestation fetus did not affect fetal kidney nephron number(Reference Zhou, Guan and Guo173). However, there was evidence for increased cellular stress, inflammation and apoptosis in the kidney of fetuses of obese dams compared to healthy controls(Reference Zhou, Guan and Guo173). Furthermore, late-gestation proteomic analysis of male fetal mouse kidneys from dams fed with a high-fat diet showed differential expression of proteins linked to transcription/translation, mitochondrial processes and membrane remodelling compared to offspring of controls(Reference Nüsken, Turnwald and Fink174).

Postnatally, studies in rodents have found that young offspring of dams fed with an obesogenic diet have impaired renal structure, function and inflammation(Reference Shamseldeen, Ali Eshra and Ahmed Rashed175). This persists in adulthood with increased renal inflammation, oxidative stress and fibrosis(Reference Glastras, Chen and McGrath176Reference Yamada-Obara, Yamagishi and Taguchi178), accompanied by markers of kidney dysfunction(Reference Armitage, Lakasing and Taylor158,Reference Yamada-Obara, Yamagishi and Taguchi178) in both the presence(Reference Yamada-Obara, Yamagishi and Taguchi178) and absence(Reference Armitage, Lakasing and Taylor158) of altered renal histology. A potential mechanism for the programming of offspring renal dysfunction is maternal obesity-induced depression of sirtuin 1 expression(Reference Nguyen, Chen and Pollock179), a key regulator promoting lipid utilisation and suppressing lipogenesis. In an mouse model, both overexpression and administration of a sirtuin 1 activator were able to attenuate some, but not all, of the negative programming effects of maternal obesity in the offspring kidney(Reference Nguyen, Mak and Chen180). Exposure to maternal obesity in utero may also lead to increased offspring susceptibility to subsequent renal injury, with enhanced offspring renal damage following streptozotocin-induced diabetes(Reference Glastras, Tsang and Teh177), as well as enhanced renal inflammation, fibrosis, glomerulosclerosis and kidney dysfunction in mouse and rat offspring challenged with a postnatal obesogenic diet(Reference Glastras, Chen and McGrath176,Reference Jackson, Alexander and Roach181,Reference Flynn, Alexander and Lee182) .

Studies which have investigated offspring outcomes in both male and female offspring suggest there may be differences in the programming of offspring renal damage by maternal obesity(Reference Nguyen, Chen and Pollock179,Reference Tain, Lin and Sheen183) , although there are some inconsistencies as to which sex is more vulnerable to adverse effects. For example, a rat model of maternal diet-induced obesity has shown increased renal lipid accumulation and more prominent renal fibrosis in male offspring(Reference Nguyen, Chen and Pollock179), while in contrast another study has shown that maternal diet-induced obesity resulted in greater changes in the female rat offspring renal transcriptome, compared to males(Reference Tain, Lin and Sheen183).

Overall maternal obesity has been shown to affect offspring renal and vascular function, predisposing offspring to increased risk of developing hypertension in later life (Fig. 1).

Exercise interventions in obese pregnancy

Evidence from human studies

With the significant body of evidence associating maternal obesity with adverse offspring cardiometabolic outcomes (Fig. 1), there is a clear need for the development of effective interventions in obese pregnancy to protect offspring health. In human subjects, intervention studies exploring the effects of exercise during overweight or obese pregnancy either alone(Reference Seneviratne, Jiang and Derraik184Reference Dekker Nitert, Barrett and Denny197) or combined with other lifestyle and dietary changes(Reference Mottola, Giroux and Gratton198Reference Petrella, Malavolti and Bertarini221) have shown mixed and somewhat inconsistent success for the prevention of adverse maternal, pregnancy and neonatal outcomes.

In terms of maternal outcomes, gestational weight gain was shown to be reduced by exercise intervention in some studies(Reference Wang, Wei and Zhang188,Reference Bisson, Alméras and Dufresne189,Reference Daly, Farren and McKeating192,Reference Mottola, Giroux and Gratton198,Reference Poston, Bell and Croker200,Reference Simmons, Devlieger and van Assche205,Reference Vinter, Jensen and Ovesen210,Reference Renault, Nørgaard and Nilas211,Reference Claesson, Sydsjö and Brynhildsen216,Reference Shirazian, Monteith and Friedman217,Reference Bogaerts, Devlieger and Nuyts219Reference Petrella, Malavolti and Bertarini221) , although not in others(Reference Seneviratne, Jiang and Derraik184,Reference Garnæs, Mørkved and Salvesen185,Reference Nascimento, Surita and Parpinelli193,Reference Dekker Nitert, Barrett and Denny197,Reference Dodd, Turnbull and McPhee199,Reference Rönö, Grotenfelt and Klemetti207,Reference Phelan, Phipps and Abrams215,Reference Guelinckx, Devlieger and Mullie218) . There is some evidence of reduced maternal adiposity(Reference Poston, Bell and Croker200) and post-partum weight retention(Reference Kong, Campbell and Wagner191,Reference Mottola, Giroux and Gratton198,Reference Phelan, Phipps and Abrams215) with exercise interventions during pregnancy, although this is not consistent across all studies(Reference Seneviratne, Jiang and Derraik184,Reference Garnæs, Mørkved and Salvesen185) . A similar pattern is seen for incidence of gestational diabetes with evidence of reduced risk by intervention in some(Reference Garnæs, Mørkved and Salvesen185,Reference Wang, Wei and Zhang188,Reference Ong, Guelfi and Hunter194,Reference Dieberger, Desoye and Stolz208,Reference Brankston, Mitchell and Ryan214,Reference Petrella, Malavolti and Bertarini221) , but not all cohorts(Reference Bisson, Alméras and Dufresne189,Reference Daly, Farren and McKeating192,Reference Callaway, Colditz and Byrne196,Reference Poston, Bell and Croker200,Reference Simmons, Devlieger and van Assche205,Reference Rönö, Grotenfelt and Klemetti207,Reference Vinter, Tanvig and Christensen209,Reference Vinter, Jensen and Ovesen210,Reference Kennelly, Ainscough and Lindsay213,Reference Phelan, Phipps and Abrams215,Reference Shirazian, Monteith and Friedman217) . Physical activity interventions were also shown to promote improved maternal vascular function with decreased blood pressure reported in some(Reference Garnæs, Mørkved and Salvesen185,Reference Petrella, Malavolti and Bertarini221) , but not all(Reference Nascimento, Surita and Parpinelli193,Reference Vinter, Jensen and Ovesen210) studies. Some studies also suggest that maternal exercise intervention promotes improved maternal cardiorespiratory fitness(Reference Seneviratne, Jiang and Derraik184,Reference Bisson, Alméras and Dufresne189,Reference Santos, Stein and Fuchs190) and metabolic profiles(Reference Mills, Patel and White203), although results were again inconsistent(Reference Dekker Nitert, Barrett and Denny197,Reference Renault, Carlsen and Hædersdal212) .

Generally no effects of exercise interventions have been observed on birth weight or frequency of large for gestational age infants(Reference Seneviratne, Jiang and Derraik184,Reference Garnæs, Nyrnes and Salvesen186,Reference Bisson, Alméras and Dufresne189,Reference Daly, Farren and McKeating192,Reference Nascimento, Surita and Parpinelli193,Reference Oostdam, van Poppel and Wouters195,Reference Dekker Nitert, Barrett and Denny197Reference Poston, Bell and Croker200,Reference Vinter, Jensen and Ovesen210,Reference Phelan, Phipps and Abrams215Reference Bogaerts, Devlieger and Nuyts219) , although some studies did report reduced birth weight(Reference Wang, Wei and Zhang188). There is also, albeit inconsistent(Reference Garnæs, Nyrnes and Salvesen186,Reference Kong, Campbell and Wagner191,Reference Dekker Nitert, Barrett and Denny197) , evidence of reduced adiposity in neonates(Reference van Poppel, Simmons and Devlieger206) and 6 month old infants(Reference Patel, Godfrey and Pasupathy201), although this phenotype was lost by 3 years(Reference Dalrymple, Tydeman and Taylor204). Analysis of cord blood metabolites has shown no difference in some studies(Reference Dekker Nitert, Barrett and Denny197,Reference Patel, Hellmuth and Uhl202) , while others reported reduced cord leptin levels(Reference van Poppel, Simmons and Devlieger206). Few studies have considered the offspring cardiovascular system, however one study suggested that exercise intervention in maternal obesity does not affect newborn systolic or diastolic cardiac functional parameters(Reference Nyrnes, Garnæs and Salvesen187), although there is evidence of reduced resting pulse rate in 3 year old offspring(Reference Dalrymple, Tydeman and Taylor204), which may indicate reduced cardiovascular risk.

The large variation in human intervention studies may be due to a combination of the different intervention protocols utilised, poor adherence to intervention programmes(Reference Seneviratne, Jiang and Derraik184,Reference Nyrnes, Garnæs and Salvesen187,Reference Oostdam, van Poppel and Wouters195,Reference Phelan, Phipps and Abrams215) and variations in factors such as population ethnicity. Furthermore, due to the time scales involved in follow-up studies, there is a severe lack of long-term offspring data for the effect of maternal exercise intervention in the context of obese pregnancy, with the oldest study to date following offspring up to 3 years of age(Reference Dalrymple, Tydeman and Taylor204). Thus, animal models are an important tool to investigate the long-term effects of exercise interventions on offspring health, as well as underlying mechanisms.

Evidence from animal models

Most studies of maternal exercise intervention in obese pregnancy have been carried out in rodent models. Although there is some variation in the nature of the intervention with different studies utilising voluntary or involuntary wheel running(Reference Bae-Gartz, Janoschek and Kloppe48,Reference Vega, Reyes-Castro and Bautista222Reference Zheng, Alves-Wagner and Stanford230) , treadmill running(Reference Beeson, Blackmore and Carr128,Reference Fernandez-Twinn, Gascoin and Musial231Reference Son, Zhao and Chen235) or swimming(Reference Zhu, Ma and Ye236), some consistent patterns have emerged in terms of maternal and offspring outcomes.

Rodent models have shown that exercise interventions can improve the maternal metabolic profile, including improvement of the impaired glucose tolerance, increased insulin concentrations and impaired insulin signalling usually seen in obese dams(Reference Vega, Reyes-Castro and Bautista222,Reference Fernandez-Twinn, Gascoin and Musial231Reference Musial, Fernandez-Twinn and Duque-Guimaraes233) , although not maternal weight or adiposity(Reference Bae-Gartz, Janoschek and Kloppe48,Reference Vega, Reyes-Castro and Bautista222,Reference Raipuria, Bahari and Morris223,Reference Fernandez-Twinn, Gascoin and Musial231,Reference Musial, Fernandez-Twinn and Duque-Guimaraes233) . Exercise intervention during obese rodent pregnancy can also partially prevent some aspects of increased oxidative stress in maternal tissues(Reference Vega, Reyes-Castro and Bautista222) and the placenta(Reference Fernandez-Twinn, Gascoin and Musial231). Furthermore, maternal exercise prevents obesity-induced increases in rodent placental lipid accumulation, inflammation and alterations in placental morphology to reduce vascularisation(Reference Fernandez-Twinn, Gascoin and Musial231,Reference Son, Liu and Tian232) .

In the offspring, the elevated blood glucose and insulin levels seen in both male and female offspring of obese rodent dams can be improved in the pup(Reference Raipuria, Bahari and Morris223) and adult offspring(Reference Bae-Gartz, Janoschek and Kloppe48,Reference Vega, Reyes-Castro and Bautista222,Reference Stanford, Lee and Getchell225Reference Laker, Altıntaş and Lillard228,Reference Fernandez-Twinn, Gascoin and Musial231,Reference Ribeiro, Tófolo and Martins234,Reference Zhu, Ma and Ye236) by exercise intervention during pregnancy. Maternal exercise intervention is also protective against other adverse effects of maternal obesity in rats and mice, including preventing increased adiposity(Reference Stanford, Lee and Getchell225,Reference Ribeiro, Tófolo and Martins234,Reference Zhu, Ma and Ye236) , cognitive impairment(Reference Moser, McDaniel and Woolard229), dysregulation of hypothalamic gene expression(Reference Bae-Gartz, Janoschek and Kloppe48), hepatic dysfunction and insulin resistance(Reference Stanford, Takahashi and So226), epigenetic and transcriptional changes in skeletal muscle leading to impaired muscle oxidative capacity(Reference Raipuria, Bahari and Morris223,Reference Laker, Lillard and Okutsu227,Reference Laker, Altıntaş and Lillard228) , increased inflammation(Reference Bae-Gartz, Janoschek and Kloppe48) and β-cell dysfunction(Reference Zheng, Alves-Wagner and Stanford230). However, few studies have specifically investigated the effects of exercise intervention in obese pregnancy on offspring cardiovascular function(Reference Beeson, Blackmore and Carr128). In male mice it has been shown that maternal exercise prevents cardiac hypertrophy and dysfunction in offspring of obese dams, however there was no such protective effect seen on offspring vasculature with no reversal of increased systolic blood pressure or increased aortic diameter by maternal exercise intervention(Reference Beeson, Blackmore and Carr128).

Some mouse studies have suggested that the positive effects of maternal exercise intervention on obese pregnancies may be mediated via improvement of maternal hyperinsulinaemia, which may be sufficient to prevent offspring hyperinsulinaemia(Reference Fernandez-Twinn, Gascoin and Musial231), adipose tissue insulin resistance(Reference Fernandez-Twinn, Gascoin and Musial231) and cardiac dysfunction(Reference Beeson, Blackmore and Carr128). However, as maternal exercise has not been shown to rescue the programming of offspring hypertension in rodents(Reference Beeson, Blackmore and Carr128), other programming factors may also be involved. One candidate for the programming of hypertension is maternal hyperleptinaemia, as this is not corrected by maternal exercise in rodents(Reference Vega, Reyes-Castro and Bautista222,Reference Fernandez-Twinn, Gascoin and Musial231) .

Similar to the programming of the offspring cardiometabolic phenotype by maternal obesity discussed in previous sections, the effects of exercise intervention on early life also show some sexual dimorphism. Some studies have shown greater benefits to the more severely affected male rat pups(Reference Raipuria, Bahari and Morris223), while in contrast, in weaning mouse offspring, maternal exercise intervention has been shown to be more effective in females, with female-specific improved metabolic characteristics(Reference Zhu, Ma and Ye236). However, in other mouse studies the degree of metabolic improvement conferred to adult offspring by maternal exercise appears similar for both sexes(Reference Stanford, Lee and Getchell225,Reference Stanford, Takahashi and So226) .

Thus, maternal exercise in obese pregnancy, while showing varied success in human trials, does appear to be an effective potential intervention to protect offspring from the long-term programming of cardiometabolic disease by maternal obesity. A greater number of high-quality human intervention studies, with better compliance and longer term follow-up, are required in order to validate these observations seen in animal models.

Conclusions

In conclusion, maternal obesity can programme offspring cardiometabolic disease, with the impact of maternal obesity beginning in early life, and persisting throughout adulthood. This includes the programming of increased offspring risk of adiposity, type 2 diabetes, cardiac dysfunction and hypertension (Fig. 1). Maternal exercise interventions have the potential to mitigate some, although not all, of the adverse effects of maternal obesity on offspring health. Thus alternative interventions, such as diet and antioxidant therapies(Reference Schoonejans and Ozanne237), either alone or in combination, are also avenues of future potential research to prevent transmission of poor cardiometabolic health from mother to child.

Financial Support

This study was supported by the British Heart Foundation (I. I., FS/18/56/35177), (S. E. O., RG/17/12/33167); and the Medical Research Council (S. E. O., MC_UU_00014/4). The British Heart Foundation and Medical Research Council had no role in the design, analysis or writing of this article.

Conflict of Interest

None.

Authorship

S. E. O. conceived the review. I. I. drafted the manuscript and prepared the figure. S. E. O. and I. I. revised the manuscript.

References

WHO (2018) World Health Organisation – Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed 29 April 2019).Google Scholar
Dobbs, R, Sawers, C, Thompson, F et al. (2014) Overcoming obesity: An initial economic analysis. McKinsey global institute.Google Scholar
WHO (2018) World Health Organisation – Cardiovascular Diseases (CVDs). https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 23 January 2019).Google Scholar
WHO (2021) Non-communicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed 22 December 2021).Google Scholar
Davies, SC (2014) Chief Medical Officer Annual Report 2014: Women's Health. Lond. Dep. Health.Google Scholar
Poston, L, Caleyachetty, R, Cnattingius, S et al. (2016) Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol 4, 10251036.CrossRefGoogle ScholarPubMed
Zambrano, E, Ibáñez, C, Martínez-Samayoa, PM et al. (2016) Maternal obesity: lifelong metabolic outcomes for offspring from poor developmental trajectories during the perinatal period. Arch Med Res 47, 112.CrossRefGoogle ScholarPubMed
Barker, DJ, Osmond, C, Golding, J et al. (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 298, 564567.CrossRefGoogle ScholarPubMed
Barker, DJ, Winter, PD, Osmond, C et al. (1989) Weight in infancy and death from ischaemic heart disease. Lancet 2, 577580.CrossRefGoogle ScholarPubMed
Hales, CN, Barker, DJ, Clark, PM et al. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303, 10191022.CrossRefGoogle ScholarPubMed
Eriksson, JG, Forsén, T, Tuomilehto, J et al. (1999) Catch-up growth in childhood and death from coronary heart disease: longitudinal study. Br Med J 318, 427431.CrossRefGoogle ScholarPubMed
Roseboom, T, de Rooij, S & Painter, R (2006) The Dutch famine and its long-term consequences for adult health. Early Hum Dev 82, 485491.CrossRefGoogle ScholarPubMed
Stein, CE, Fall, CH, Kumaran, K et al. (1996) Fetal growth and coronary heart disease in south India. Lancet 348, 12691273.CrossRefGoogle ScholarPubMed
Eriksson, JG, Sandboge, S, Salonen, MK et al. (2014) Long-term consequences of maternal overweight in pregnancy on offspring later health: findings from the Helsinki birth cohort study. Ann Med 46, 434438.CrossRefGoogle ScholarPubMed
Reynolds, RM, Allan, KM, Raja, EA et al. (2013) Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. Br Med J 347, f4539.CrossRefGoogle ScholarPubMed
Sørensen, TI, Holst, C & Stunkard, AJ (1998) Adoption study of environmental modifications of the genetic influences on obesity. Int J Obes Relat Metab Disord J Int Assoc Study Obes 22, 7381.CrossRefGoogle ScholarPubMed
Sørensen, TI, Holst, C & Stunkard, AJ (1992) Childhood body mass index – genetic and familial environmental influences assessed in a longitudinal adoption study. Int J Obes Relat Metab Disord J Int Assoc Study Obes 16, 705714.Google Scholar
Smith, J, Cianflone, K, Biron, S et al. (2009) Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab 94, 42754283.CrossRefGoogle ScholarPubMed
Kral, JG, Biron, S, Simard, S et al. (2006) Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics 118, e1644e1649.CrossRefGoogle ScholarPubMed
Guénard, F, Deshaies, Y, Cianflone, K et al. (2013) Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci USA 110, 1143911444.CrossRefGoogle ScholarPubMed
Ehrenberg, HM, Mercer, BM & Catalano, PM (2004) The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 191, 964968.CrossRefGoogle ScholarPubMed
Sewell, MF, Huston-Presley, L, Super, DM et al. (2006) Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 195, 11001103.CrossRefGoogle Scholar
Whitelaw, AG (1976) Influence of maternal obesity on subcutaneous fat in the newborn. Br Med J 1, 985986.CrossRefGoogle ScholarPubMed
Schack-Nielsen, L, Michaelsen, KF, Gamborg, M et al. (2010) Gestational weight gain in relation to offspring body mass index and obesity from infancy through adulthood. Int J Obes 2005, 6774.CrossRefGoogle Scholar
Salsberry, PJ & Reagan, PB (2005) Dynamics of early childhood overweight. Pediatrics 116, 13291338.CrossRefGoogle ScholarPubMed
Andres, A, Hull, HR, Shankar, K et al. (2015) Longitudinal body composition of children born to mothers with normal weight, overweight, and obesity. Obesity 23, 12521258.CrossRefGoogle ScholarPubMed
Gale, CR, Javaid, MK, Robinson, SM et al. (2007) Maternal size in pregnancy and body composition in children. J Clin Endocrinol Metab 92, 39043911.CrossRefGoogle ScholarPubMed
Gaillard, R, Steegers, EAP, Duijts, L et al. (2014) Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the generation R study. Hypertension 1979, 683691.CrossRefGoogle Scholar
Kaar, JL, Crume, T, Brinton, JT et al. (2014) Maternal obesity, gestational weight gain and offspring adiposity: the EPOCH study. J Pediatr 165, 509515.CrossRefGoogle Scholar
Whitaker, RC, Wright, JA, Pepe, MS et al. (1997) Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 337, 869873.CrossRefGoogle ScholarPubMed
Castillo-Laura, H, Santos, IS, Quadros, LCM et al. (2015) Maternal obesity and offspring body composition by indirect methods: a systematic review and meta-analysis. Cad Saúde Pública 31, 20732092.CrossRefGoogle ScholarPubMed
Liang, X, Yang, Q, Fu, X et al. (2016) Maternal obesity epigenetically alters visceral fat progenitor cell properties in male offspring mice. J Physiol 594, 44534466.CrossRefGoogle ScholarPubMed
Zambrano, E, Martínez-Samayoa, PM, Rodríguez-González, GL et al. (2010) Dietary intervention prior to pregnancy reverses metabolic programming in male offspring of obese rats. J Physiol 588, 17911799.CrossRefGoogle ScholarPubMed
Lecoutre, S, Deracinois, B, Laborie, C et al. (2016) Depot- and sex-specific effects of maternal obesity in offspring's adipose tissue. J Endocrinol 230, 3953.CrossRefGoogle ScholarPubMed
Litzenburger, T, Huber, E-K, Dinger, K et al. (2020) Maternal high-fat diet induces long-term obesity with sex-dependent metabolic programming of adipocyte differentiation, hypertrophy and dysfunction in the offspring. Clin Sci 1979, 921939.CrossRefGoogle Scholar
Huypens, P, Sass, S, Wu, M et al. (2016) Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Nat Genet 48, 497499.CrossRefGoogle ScholarPubMed
Sun, B, Purcell, RH, Terrillion, CE et al. (2012) Maternal high-fat diet during gestation or suckling differentially affects offspring leptin sensitivity and obesity. Diabetes 61, 28332841.CrossRefGoogle ScholarPubMed
Desai, M, Jellyman, JK, Han, G et al. (2014) Maternal obesity and high-fat diet program offspring metabolic syndrome. Am J Obstet Gynecol 211, 237.e1237.e13.CrossRefGoogle ScholarPubMed
Liang, C, Oest, ME & Prater, MR (2009) Intrauterine exposure to high saturated fat diet elevates risk of adult-onset chronic diseases in C57BL/6 mice. Birth Defects Res B Dev Reprod Toxicol 86, 377384.CrossRefGoogle ScholarPubMed
Chang, E, Hafner, H, Varghese, M et al. (2019) Programming effects of maternal and gestational obesity on offspring metabolism and metabolic inflammation. Sci Rep 9, 16027.CrossRefGoogle ScholarPubMed
Fensterseifer, SR, Austin, KJ, Ford, SP et al. (2018) Effects of maternal obesity on maternal and fetal plasma concentrations of adiponectin and expression of adiponectin and its receptor genes in cotyledonary and adipose tissues at mid- and late-gestation in sheep. Anim Reprod Sci 197, 231239.CrossRefGoogle ScholarPubMed
Long, NM, Rule, DC, Zhu, MJ et al. (2012) Maternal obesity upregulates fatty acid and glucose transporters and increases expression of enzymes mediating fatty acid biosynthesis in fetal adipose tissue depots. J Anim Sci 90, 22012210.CrossRefGoogle ScholarPubMed
Lewis, DS, Bertrand, HA, McMahan, CA et al. (1986) Preweaning food intake influences the adiposity of young adult baboons. J Clin Invest 78, 899905.CrossRefGoogle ScholarPubMed
Menting, MD, Mintjens, S, van de Beek, C et al. (2019) Maternal obesity in pregnancy impacts offspring cardiometabolic health: systematic review and meta-analysis of animal studies. Obes Rev 20, 675685.CrossRefGoogle ScholarPubMed
Murabayashi, N, Sugiyama, T, Zhang, L et al. (2013) Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. Eur J Obstet Gynecol Reprod Biol 169, 3944.CrossRefGoogle ScholarPubMed
Muhlhausler, BS, Duffield, JA & McMillen, IC (2007) Increased maternal nutrition stimulates peroxisome proliferator activated receptor-γ, adiponectin, and leptin messenger ribonucleic acid expression in adipose tissue before birth. Endocrinology 148, 878885.CrossRefGoogle ScholarPubMed
Sen, S & Simmons, RA (2010) Maternal antioxidant supplementation prevents adiposity in the offspring of western diet-fed rats. Diabetes 59, 30583065.CrossRefGoogle ScholarPubMed
Bae-Gartz, I, Janoschek, R, Kloppe, C-S et al. (2016) Running exercise in obese pregnancies prevents IL-6 trans-signaling in male offspring. Med Sci Sports Exerc 48, 829838.CrossRefGoogle ScholarPubMed
Alfaradhi, MZ, Kusinski, LC, Fernandez-Twinn, DS et al. (2016) Maternal obesity in pregnancy developmentally programs adipose tissue inflammation in young, lean male mice offspring. Endocrinology 157, 42464256.CrossRefGoogle ScholarPubMed
Chang, G-Q, Gaysinskaya, V, Karatayev, O et al. (2008) Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity. J Neurosci 28, 1210712119.CrossRefGoogle ScholarPubMed
Nguyen, LT, Saad, S, Tan, Y et al. (2017) Maternal high-fat diet induces metabolic stress response disorders in offspring hypothalamus. J Mol Endocrinol 59, 8192.CrossRefGoogle ScholarPubMed
Kirk, SL, Samuelsson, A-M, Argenton, M et al. (2009) Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS ONE 4, e5870.CrossRefGoogle ScholarPubMed
Glavas, MM, Kirigiti, MA, Xiao, XQ et al. (2010) Early overnutrition results in early-onset arcuate leptin resistance and increased sensitivity to high-fat diet. Endocrinology 151, 15981610.CrossRefGoogle ScholarPubMed
Long, NM, Ford, SP & Nathanielsz, PW (2011) Maternal obesity eliminates the neonatal lamb plasma leptin peak. J Physiol 589, 14551462.CrossRefGoogle ScholarPubMed
Muhlhausler, BS, Duffield, JA & McMillen, IC (2007) Increased maternal nutrition increases leptin expression in perirenal and subcutaneous adipose tissue in the postnatal lamb. Endocrinology 148, 61576163.CrossRefGoogle ScholarPubMed
Gupta, A, Srinivasan, M, Thamadilok, S et al. (2009) Hypothalamic alterations in fetuses of high fat diet-fed obese female rats. J Endocrinol 200, 293300.CrossRefGoogle ScholarPubMed
Vogt, MC, Paeger, L, Hess, S et al. (2014) Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding. Cell 156, 495509.CrossRefGoogle ScholarPubMed
Dearden, L, Buller, S, Furigo, IC et al. (2020) Maternal obesity causes fetal hypothalamic insulin resistance and disrupts development of hypothalamic feeding pathways. Mol Metab 42, 101079.CrossRefGoogle ScholarPubMed
Galicia-Garcia, U, Benito-Vicente, A, Jebari, S et al. (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21, 6275.CrossRefGoogle ScholarPubMed
Catalano, PM, Presley, L, Minium, J et al. (2009) Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 32, 10761080.CrossRefGoogle ScholarPubMed
Maftei, O, Whitrow, MJ, Davies, MJ et al. (2015) Maternal body size prior to pregnancy, gestational diabetes and weight gain: associations with insulin resistance in children at 9–10 years. Diabet Med 32, 174180.CrossRefGoogle ScholarPubMed
Dabelea, D, Mayer-Davis, EJ, Lamichhane, AP et al. (2008) Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH case-control study. Diabetes Care 31, 14221426.CrossRefGoogle ScholarPubMed
Boney, CM, Verma, A, Tucker, R et al. (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115, e290e296.CrossRefGoogle ScholarPubMed
Hochner, H, Friedlander, Y, Calderon-Margalit, R et al. (2012) Associations of maternal pre-pregnancy body mass index and gestational weight gain with adult offspring cardio-metabolic risk factors: the Jerusalem perinatal family follow-up study. Circulation 125, 13811389.CrossRefGoogle Scholar
Fall, CH, Stein, CE, Kumaran, K et al. (1998) Size at birth, maternal weight, and type 2 diabetes in South India. Diabet Med 15, 220227.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Lahti-Pulkkinen, M, Bhattacharya, S, Wild, SH et al. (2019) Consequences of being overweight or obese during pregnancy on diabetes in the offspring: a record linkage study in Aberdeen, Scotland. Diabetologia 62, 14121419.CrossRefGoogle ScholarPubMed
Rajia, S, Chen, H & Morris, MJ (2010) Maternal overnutrition impacts offspring adiposity and brain appetite markers-modulation by postweaning diet. J Neuroendocrinol 22, 905914.Google ScholarPubMed
Taylor, PD, McConnell, J, Khan, IY et al. (2005) Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy. Am J Physiol Regul Integr Comp Physiol 288, R134R139.CrossRefGoogle ScholarPubMed
Zambrano, E, Sosa-Larios, T, Calzada, L et al. (2016) Decreased basal insulin secretion from pancreatic islets of pups in a rat model of maternal obesity. J Endocrinol 231, 4957.CrossRefGoogle Scholar
Buckley, AJ, Keserü, B, Briody, J et al. (2005) Altered body composition and metabolism in the male offspring of high fat-fed rats. Metabolism 54, 500507.CrossRefGoogle ScholarPubMed
Yokomizo, H, Inoguchi, T, Sonoda, N et al. (2014) Maternal high-fat diet induces insulin resistance and deterioration of pancreatic β-cell function in adult offspring with sex differences in mice. Am J Physiol Endocrinol Metab 306, E1163E1175.CrossRefGoogle ScholarPubMed
Alfaradhi, MZ, Fernandez-Twinn, DS, Martin-Gronert, MS et al. (2014) Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. Am J Physiol Regul Integr Comp Physiol 307, R26R34.CrossRefGoogle ScholarPubMed
Samuelsson, A-M, Matthenws, PA, Argenton, M et al. (2008) Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance. Hypertension 51, 383392.CrossRefGoogle Scholar
Fernandez-Twinn, DS, Alfaradhi, MZ, Martin-Gronert, MS et al. (2014) Downregulation of IRS-1 in adipose tissue of offspring of obese mice is programmed cell-autonomously through post-transcriptional mechanisms. Mol Metab 3, 325333.CrossRefGoogle ScholarPubMed
Shankar, K, Harrell, A, Liu, X et al. (2008) Maternal obesity at conception programs obesity in the offspring. Am J Physiol Regul Integr Comp Physiol 294, R528R538.CrossRefGoogle ScholarPubMed
Oben, JA, Patel, T, Mouralidarane, A et al. (2010) Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun 394, 2428.CrossRefGoogle ScholarPubMed
Graus-Nunes, F, Dalla Corte Frantz, E, Lannes, WR et al. (2015) Pregestational maternal obesity impairs endocrine pancreas in male F1 and F2 progeny. Nutrition 31, 380387.CrossRefGoogle ScholarPubMed
Han, J, Xu, J, Epstein, PN et al. (2005) Long-term effect of maternal obesity on pancreatic beta cells of offspring: reduced beta cell adaptation to high glucose and high-fat diet challenges in adult female mouse offspring. Diabetologia 48, 18101818.CrossRefGoogle ScholarPubMed
Li, CCY, Young, PE, Maloney, CA et al. (2013) Maternal obesity and diabetes induces latent metabolic defects and widespread epigenetic changes in isogenic mice. Epigenetics 8, 602611.CrossRefGoogle ScholarPubMed
Yokomizo, T, Hasegawa, K, Ishitobi, H et al. (2008) Runx1 is involved in primitive erythropoiesis in the mouse. Blood 111, 40754080.CrossRefGoogle ScholarPubMed
Akhaphong, B, Gregg, B, Kumusoglu, D et al. (2022) Maternal high-fat diet during pre-conception and gestation predisposes adult female offspring to metabolic dysfunction in mice. Front Endocrinol 12, 780300.CrossRefGoogle ScholarPubMed
Dearden, L & Balthasar, N (2014) Sexual dimorphism in offspring glucose-sensitive hypothalamic gene expression and physiological responses to maternal high-fat diet feeding. Endocrinology 155, 21442154.CrossRefGoogle ScholarPubMed
Yan, X, Zhu, MJ, Xu, W et al. (2010) Up-regulation of toll-like receptor 4/nuclear factor-κB signaling Is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation. Endocrinology 151, 380387.CrossRefGoogle ScholarPubMed
Qiao, L, Wattez, J-S, Lim, L et al. (2019) Prolonged prepregnant maternal high-fat feeding reduces fetal and neonatal blood glucose concentrations by enhancing fetal β-cell development in C57BL/6 mice. Diabetes 68, 16041613.CrossRefGoogle ScholarPubMed
Yan, X, Huang, Y, Zhao, J-X et al. (2011) Maternal obesity-impaired insulin signaling in sheep and induced lipid accumulation and fibrosis in skeletal muscle of offspring. Biol Reprod 85, 172178.CrossRefGoogle ScholarPubMed
Nicholas, LM, Morrison, JL, Rattanatray, L et al. (2013) Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age. PLoS ONE 8, e84594.CrossRefGoogle ScholarPubMed
de Fante, T, Simino, LA, Reginato, A et al. (2016) Diet-induced maternal obesity alters insulin signalling in male mice offspring rechallenged with a high-fat diet in adulthood. PLoS ONE 11, e0160184.CrossRefGoogle Scholar
Shelley, P, Martin-Gronert, MS, Rowlerson, A et al. (2009) Altered skeletal muscle insulin signaling and mitochondrial complex II–III linked activity in adult offspring of obese mice. Am J Physiol Regul Integr Comp Physiol 297, R675R681.CrossRefGoogle ScholarPubMed
Bayol, SA, Simbi, BH & Stickland, NC (2005) A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning. J Physiol 567, 951961.CrossRefGoogle ScholarPubMed
Puppala, S, Li, C, Glenn, JP et al. (2018) Primate fetal hepatic responses to maternal obesity: epigenetic signalling pathways and lipid accumulation. J Physiol 596, 58235837.CrossRefGoogle ScholarPubMed
Martin-Gronert, MS, Fernandez-Twinn, DS, Poston, L et al. (2010) Altered hepatic insulin signalling in male offspring of obese mice. J Dev Orig Health Dis 1, 184191.CrossRefGoogle ScholarPubMed
Nicholas, LM, Rattanatray, L, MacLaughlin, SM et al. (2013) Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring. FASEB J 27, 37863796.CrossRefGoogle ScholarPubMed
Rattanatray, L, Muhlhausler, BS, Nicholas, LM et al. (2014) Impact of maternal overnutrition on gluconeogenic factors and methylation of the phosphoenolpyruvate carboxykinase promoter in the fetal and postnatal liver. Pediatr Res 75, 1421.CrossRefGoogle ScholarPubMed
Lomas-Soria, C, Reyes-Castro, LA, Rodríguez-González, GL et al. (2018) Maternal obesity has sex-dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring. J Physiol 596, 46114628.CrossRefGoogle ScholarPubMed
Ford, SP, Zhang, L, Zhu, M et al. (2009) Maternal obesity accelerates fetal pancreatic β-cell but not α-cell development in sheep: prenatal consequences. Am J Physiol Regul Integr Comp Physiol 297, R835.CrossRefGoogle Scholar
Zhang, L, Long, NM, Hein, SM et al. (2011) Maternal obesity in ewes results in reduced fetal pancreatic β-cell numbers in late gestation and decreased circulating insulin concentration at term. Domest Anim Endocrinol 40, 3039.CrossRefGoogle ScholarPubMed
Bringhenti, I, Moraes-Teixeira, JA, Cunha, MR et al. (2013) Maternal obesity during the preconception and early life periods alters pancreatic development in early and adult life in male mouse offspring. PLoS ONE 8, e55711.CrossRefGoogle ScholarPubMed
Cerf, ME, Williams, K, Nkomo, XI et al. (2005) Islet cell response in the neonatal rat after exposure to a high-fat diet during pregnancy. Am J Physiol Regul Integr Comp Physiol 288, R1122R1128.CrossRefGoogle ScholarPubMed
Cerf, ME & Louw, J (2014) Islet cell response to high fat programming in neonate, weanling and adolescent Wistar rats. J Pancreas 15, 228236.Google ScholarPubMed
Zheng, J, Zhang, L, Wang, Z et al. (2020) Maternal high-fat diet regulates glucose metabolism and pancreatic β cell phenotype in mouse offspring at weaning. PeerJ 8, e9407.CrossRefGoogle ScholarPubMed
Cerf, ME, Muller, CJ, Toit, DFD et al. (2006) Hyperglycaemia and reduced glucokinase expression in weanling offspring from dams maintained on a high-fat diet. Br J Nutr 95, 391396.CrossRefGoogle ScholarPubMed
Casasnovas, J, Damron, CL, Jarrell, J et al. (2021) Offspring of obese dams exhibit sex-differences in pancreatic heparan sulfate glycosaminoglycans and islet insulin secretion. Front Endocrinol 12, 658439.CrossRefGoogle ScholarPubMed
Nicholas, LM, Nagao, M, Kusinski, LC et al. (2020) Exposure to maternal obesity programs sex differences in pancreatic islets of the offspring in mice. Diabetologia 63, 324337.CrossRefGoogle ScholarPubMed
Liu, X, Ding, G, Yang, W et al. (2019) Maternal body mass index and risk of congenital heart defects in infants: a dose-response meta-analysis. BioMed Res Int 2019, e1315796.Google ScholarPubMed
Ingul, CB, Lorås, L, Tegnander, E et al. (2016) Maternal obesity affects fetal myocardial function as early as in the first trimester. Ultrasound Obstet Gynecol 47, 433442.CrossRefGoogle Scholar
Kulkarni, A, Li, L, Craft, M et al. (2017) Fetal myocardial deformation in maternal diabetes mellitus and obesity. Ultrasound Obstet Gynecol 49, 630636.CrossRefGoogle ScholarPubMed
Ece, İ, Uner, A, Balli, S et al. (2014) The effects of pre-pregnancy obesity on fetal cardiac functions. Pediatr Cardiol 35, 838843.CrossRefGoogle ScholarPubMed
Mat Husin, H, Schleger, F, Bauer, I et al. (2020) Maternal weight, weight gain, and metabolism are associated with changes in fetal heart rate and variability. Obesity 28, 114121.CrossRefGoogle ScholarPubMed
Forsén, T, Eriksson, JG, Tuomilehto, J et al. (1997) Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. Br Med J 315, 837840.CrossRefGoogle Scholar
Razaz, N, Villamor, E, Muraca, GM et al. (2020) Maternal obesity and risk of cardiovascular diseases in offspring: a population-based cohort and sibling-controlled study. Lancet Diabetes Endocrinol 8, 572581.CrossRefGoogle ScholarPubMed
Cooper, R, Pinto Pereira, SM, Power, C et al. (2013) Parental obesity and risk factors for cardiovascular disease among their offspring in mid-life: findings from the 1958 British birth cohort study. Int J Obes 37, 15901596.CrossRefGoogle ScholarPubMed
Litwin, L, Sundholm, JKM, Rönö, K et al. (2020) No effect of gestational diabetes or pre-gestational obesity on 6-year offspring left ventricular function-RADIEL study follow-up. Acta Diabetol 57, 14631472, https://doi.org/10.1007/s00592-020-01571-z.CrossRefGoogle ScholarPubMed
Labayen, I, Ruiz, JR, Ortega, FB et al. (2010) Intergenerational cardiovascular disease risk factors involve both maternal and paternal BMI. Diabetes Care 33, 894900.CrossRefGoogle ScholarPubMed
Toemen, L, Gishti, O, van Osch-Gevers, L et al. (2016) Maternal obesity, gestational weight gain and childhood cardiac outcomes: role of childhood body mass index. Int J Obes 2005, 10701078.CrossRefGoogle Scholar
Kandadi, MR, Hua, Y, Zhu, M et al. (2013) Influence of gestational overfeeding on myocardial proinflammatory mediators in fetal sheep heart. J Nutr Biochem 24, 19821990.CrossRefGoogle ScholarPubMed
Fan, X, Turdi, S, Ford, SP et al. (2011) Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep. J Nutr Biochem 22, 3037.CrossRefGoogle ScholarPubMed
Dong, F, Ford, SP, Nijland, MJ et al. (2008) Influence of maternal undernutrition and overfeeding on cardiac ciliary neurotrophic factor receptor and ventricular size in fetal sheep. J Nutr Biochem 19, 409414.CrossRefGoogle ScholarPubMed
George, LA, Uthlaut, AB, Long, NM et al. (2010) Different levels of overnutrition and weight gain during pregnancy have differential effects on fetal growth and organ development. Reprod Biol Endocrinol 8, 75.CrossRefGoogle ScholarPubMed
Zhang, J, Cao, L, Tan, Y et al. (2021) N-acetylcysteine protects neonatal mice from ventricular hypertrophy induced by maternal obesity in a sex-specific manner. Biomed Pharmacother 133, 110989.CrossRefGoogle Scholar
Mdaki, KS, Larsen, TD, Wachal, AL et al. (2016) Maternal high-fat diet impairs cardiac function in offspring of diabetic pregnancy through metabolic stress and mitochondrial dysfunction. Am J Physiol Heart Circ Physiol 310, H681H692.CrossRefGoogle ScholarPubMed
Xue, Q, Chen, F, Zhang, H et al. (2019) Maternal high-fat diet alters angiotensin II receptors and causes changes in fetal and neonatal rats. Biol Reprod 100, 11931203.CrossRefGoogle Scholar
Maloyan, A, Muralimanoharan, S, Huffman, S et al. (2013) Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity. Physiol Genomics 45, 889900.CrossRefGoogle ScholarPubMed
Wang, Q, Zhu, C, Sun, M et al. (2018) Maternal obesity impairs fetal cardiomyocyte contractile function in sheep. FASEB J 33, 25872598.CrossRefGoogle ScholarPubMed
Guzzardi, MA, Liistro, T, Gargani, L et al. (2018) Maternal obesity and cardiac development in the offspring: study in human neonates and minipigs. JACC Cardiovasc Imaging 11, 17501755.CrossRefGoogle ScholarPubMed
Loche, E, Blackmore, HL, Carpenter, AA et al. (2018) Maternal diet-induced obesity programmes cardiac dysfunction in male mice independently of post-weaning diet. Cardiovasc Res 114, 13721384.CrossRefGoogle ScholarPubMed
Fernandez-Twinn, DS, Blackmore, HL, Siggens, L et al. (2012) The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology 153, 59615971.CrossRefGoogle ScholarPubMed
Blackmore, HL, Niu, Y, Fernandez-Twinn, DS et al. (2014) Maternal diet-induced obesity programs cardiovascular dysfunction in adult male mouse offspring independent of current body weight. Endocrinology 155, 39703980.CrossRefGoogle ScholarPubMed
Beeson, JH, Blackmore, HL, Carr, SK et al. (2018) Maternal exercise intervention in obese pregnancy improves the cardiovascular health of the adult male offspring. Mol Metab 16, 3544.CrossRefGoogle ScholarPubMed
Wang, J, Ma, H, Tong, C et al. (2010) Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB J 24, 20662076.CrossRefGoogle ScholarPubMed
Huang, Y, Yan, X, Zhao, JX et al. (2010) Maternal obesity induces fibrosis in fetal myocardium of sheep. Am J Physiol Endocrinol Metab 299, E968E975.CrossRefGoogle ScholarPubMed
Pantaleão, LC, Inzani, I, Furse, S et al. (2022) Maternal diet-induced obesity during pregnancy alters lipid supply to mouse E18⋅5 fetuses and changes the cardiac tissue lipidome in a sex-dependent manner. eLife 11, e69078.CrossRefGoogle Scholar
Larsen, TD, Sabey, KH, Knutson, AJ et al. (2019) Diabetic pregnancy and maternal high-fat diet impair mitochondrial dynamism in the developing fetal rat heart by sex-specific mechanisms. Int J Mol Sci 20, 3090, https://doi.org/10.3390/ijms20123090.CrossRefGoogle ScholarPubMed
Ferey, JLA, Boudoures, AL, Reid, M et al. (2019) A maternal high-fat, high-sucrose diet induces transgenerational cardiac mitochondrial dysfunction independently of maternal mitochondrial inheritance. Am J Physiol Heart Circ Physiol 316, H1202H1210.CrossRefGoogle ScholarPubMed
Lin, Y, Han, X, Fang, Z et al. (2011) Beneficial effects of dietary fibre supplementation of a high-fat diet on fetal development in rats. Br J Nutr 106, 510518.CrossRefGoogle ScholarPubMed
Upadhyaya, B, Larsen, T, Barwari, S et al. (2017) Prenatal exposure to a maternal high-fat diet affects histone modification of cardiometabolic genes in newborn rats. Nutrients 9, 407, https://doi.org/10.3390/nu9040407.CrossRefGoogle ScholarPubMed
Blin, G, Liand, M, Mauduit, C et al. (2020) Maternal exposure to high-fat diet induces long-term derepressive chromatin marks in the heart. Nutrients 12, E181.CrossRefGoogle Scholar
Turdi, S, Ge, W, Hu, N et al. (2013) Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects. J Mol Cell Cardiol 55, 117129.CrossRefGoogle ScholarPubMed
Ghnenis, AB, Odhiambo, JF, McCormick, RJ et al. (2017) Maternal obesity in the ewe increases cardiac ventricular expression of glucocorticoid receptors, proinflammatory cytokines and fibrosis in adult male offspring. PLoS ONE 12, e0189977.CrossRefGoogle ScholarPubMed
Leu, S, Wu, KLH, Lee, W-C et al. (2021) Maternal fructose intake exacerbates cardiac remodeling in offspring with ventricular pressure overload. Nutrients 13, 3267.CrossRefGoogle ScholarPubMed
Xue, Q, Chen, P, Li, X et al. (2015) Maternal high-fat diet causes a sex-dependent increase in AGTR2 expression and cardiac dysfunction in adult male rat offspring. Biol Reprod 93, 49.CrossRefGoogle ScholarPubMed
Calvert, JW, Lefer, DJ, Gundewar, S et al. (2009) Developmental programming resulting from maternal obesity: effects on myocardial ischemia/reperfusion injury. Exp Physiol 94, 805814.CrossRefGoogle Scholar
Cox, B, Luyten, LJ, Dockx, Y et al. (2020) Association between maternal prepregnancy body mass index and anthropometric parameters, blood pressure, and retinal microvasculature in children age 4 to 6 years. JAMA Netw Open 3, e204662.CrossRefGoogle ScholarPubMed
Gademan, MGJ, van Eijsden, M, Roseboom, TJ et al. (2013) Maternal prepregnancy body mass index and their children's blood pressure and resting cardiac autonomic balance at age 5 to 6 years. Hypertension 1979, 641647.CrossRefGoogle Scholar
Wen, X, Triche, EW, Hogan, JW et al. (2011) Prenatal factors for childhood blood pressure mediated by intrauterine and/or childhood growth? Pediatrics 127, e713e721.CrossRefGoogle ScholarPubMed
Laura, HC, Menezes, AB, Noal, RB et al. (2010) Maternal anthropometric characteristics in pregnancy and blood pressure among adolescents: 1993 live birth cohort, Pelotas, southern Brazil. BMC Public Health 10, 434.CrossRefGoogle ScholarPubMed
Aris, IM, Rifas-Shiman, SL, Li, L-J et al. (2019) Early-life predictors of systolic blood pressure trajectories from infancy to adolescence: findings from project Viva. Am J Epidemiol 188, 19131922.CrossRefGoogle ScholarPubMed
Filler, G, Yasin, A, Kesarwani, P et al. (2011) Big mother or small baby: which predicts hypertension? J Clin Hypertens 13, 3541.CrossRefGoogle ScholarPubMed
Laor, A, Stevenson, DK, Shemer, J et al. (1997) Size at birth, maternal nutritional status in pregnancy, and blood pressure at age 17: population based analysis. Br Med J 315, 449453.CrossRefGoogle ScholarPubMed
Eitmann, S, Mátrai, P, Németh, D et al. (2022) Maternal overnutrition elevates offspring's blood pressure – a systematic review and meta-analysis. Paediatr Perinat Epidemiol 36, 276287, https://doi.org/10.1111/ppe.12859.CrossRefGoogle ScholarPubMed
Ludwig-Walz, H, Schmidt, M, Günther, ALB et al. (2018) Maternal prepregnancy BMI or weight and offspring's blood pressure: systematic review. Matern Child Nutr 14, e12561.CrossRefGoogle ScholarPubMed
Brunton, NM, Dufault, B, Dart, A et al. (2021) Maternal body mass index, offspring body mass index, and blood pressure at 18 years: a causal mediation analysis. Int J Obes 45, 25322538.CrossRefGoogle ScholarPubMed
Sundholm, JKM, Litwin, L, Rönö, K et al. (2019) Maternal obesity and gestational diabetes: impact on arterial wall layer thickness and stiffness in early childhood – RADIEL study six-year follow-up. Atherosclerosis 284, 237244.CrossRefGoogle ScholarPubMed
Guberman, C, Jellyman, JK, Han, G et al. (2013) Maternal high-fat diet programs rat offspring hypertension and activates the adipose renin-angiotensin system. Am J Obstet Gynecol 209, e1e8.CrossRefGoogle ScholarPubMed
Khan, IY, Dekou, V, Douglas, G et al. (2005) A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regul Integr Comp Physiol 288, R127R133.CrossRefGoogle ScholarPubMed
Elahi, MM, Cagampang, FR, Mukhtar, D et al. (2009) Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. Br J Nutr 102, 514519.CrossRefGoogle ScholarPubMed
Samuelsson, A-M, Morris, A, Igosheva, N et al. (2010) Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. Hypertension 1979, 7682.CrossRefGoogle Scholar
Torrens, C, Ethirajan, P, Bruce, KD et al. (2012) Interaction between maternal and offspring diet to impair vascular function and oxidative balance in high fat fed male mice. PLoS ONE 7, e50671.CrossRefGoogle ScholarPubMed
Armitage, JA, Lakasing, L, Taylor, PD et al. (2005) Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol 565, 171184.CrossRefGoogle ScholarPubMed
Fan, L, Lindsley, SR, Comstock, SM et al. (2013) Maternal high-fat diet impacts endothelial function in nonhuman primate offspring. Int J Obes 2005, 254262.CrossRefGoogle Scholar
Ghosh, P, Bitsanis, D, Ghebremeskel, K et al. (2001) Abnormal aortic fatty acid composition and small artery function in offspring of rats fed a high fat diet in pregnancy. J Physiol 533, 815822.CrossRefGoogle ScholarPubMed
Koukkou, E, Ghosh, P, Lowy, C et al. (1998) Offspring of normal and diabetic rats fed saturated fat in pregnancy demonstrate vascular dysfunction. Circulation 98, 28992904.CrossRefGoogle ScholarPubMed
Taylor, P, Khan, I, Hanson, M et al. (2004) Impaired EDHF-mediated vasodilatation in adult offspring of rats exposed to a fat-rich diet in pregnancy. J Physiol 558, 943951.CrossRefGoogle ScholarPubMed
Gray, C, Vickers, MH, Segovia, SA et al. (2015) A maternal high fat diet programmes endothelial function and cardiovascular status in adult male offspring independent of body weight, which is reversed by maternal conjugated linoleic acid (CLA) supplementation. PLoS ONE 10, e0115994.CrossRefGoogle ScholarPubMed
Khan, IY, Taylor, PD, Dekou, V et al. (2003) Gender-linked hypertension in offspring of lard-fed pregnant rats. Hypertension 1979, 168175.CrossRefGoogle Scholar
Taylor, PD, Samuelsson, A-M & Poston, L (2014) Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta Physiol 210, 508523.CrossRefGoogle ScholarPubMed
Bouret, SG, Draper, SJ & Simerly, RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304, 108110.CrossRefGoogle ScholarPubMed
Samuelsson, A-M, Clark, J, Rudyk, O et al. (2013) Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function. Hypertension 1979, 627633.CrossRefGoogle Scholar
Macumber, I, Schwartz, S & Leca, N (2017) Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring. Pediatr Nephrol 32, 635642.CrossRefGoogle ScholarPubMed
Hsu, CW, Yamamoto, KT, Henry, RK et al. (2014) Prenatal risk factors for childhood CKD. J Am Soc Nephrol 25, 21052111.CrossRefGoogle ScholarPubMed
Lee, YQ, Lumbers, ER, Oldmeadow, C et al. (2019) The relationship between maternal adiposity during pregnancy and fetal kidney development and kidney function in infants: the Gomeroi Gaaynggal study. Physiol Rep 7, e14227.CrossRefGoogle ScholarPubMed
Luyckx, VA & Brenner, BM (2010) The clinical importance of nephron mass. J Am Soc Nephrol 21, 898910.CrossRefGoogle ScholarPubMed
Brenner, BM & Chertow, GM (1994) Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23, 171175.CrossRefGoogle ScholarPubMed
Zhou, P, Guan, H, Guo, Y et al. (2021) Maternal high-fat diet programs renal peroxisomes and activates NLRP3 inflammasome-mediated pyroptosis in the rat fetus. J Inflamm Res 14, 50955110.CrossRefGoogle ScholarPubMed
Nüsken, E, Turnwald, E-M, Fink, G et al. (2019) Maternal high fat diet and in-utero metformin exposure significantly impact upon the fetal renal proteome of male mice. J Clin Med 8, 663.CrossRefGoogle ScholarPubMed
Shamseldeen, AM, Ali Eshra, M, Ahmed Rashed, L et al. (2019) Omega-3 attenuates high fat diet-induced kidney injury of female rats and renal programming of their offsprings. Arch Physiol Biochem 125, 367377.CrossRefGoogle ScholarPubMed
Glastras, SJ, Chen, H, McGrath, RT et al. (2016) Effect of GLP-1 receptor activation on offspring kidney health in a rat model of maternal obesity. Sci Rep 6, 23525.CrossRefGoogle Scholar
Glastras, SJ, Tsang, M, Teh, R et al. (2016) Maternal obesity promotes diabetic nephropathy in rodent offspring. Sci Rep 6, 27769.CrossRefGoogle ScholarPubMed
Yamada-Obara, N, Yamagishi, S, Taguchi, K et al. (2016) Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clin Exp Nephrol 20, 853861.CrossRefGoogle ScholarPubMed
Nguyen, LT, Chen, H, Pollock, C et al. (2017) SIRT1 reduction is associated with sex-specific dysregulation of renal lipid metabolism and stress responses in offspring by maternal high-fat diet. Sci Rep 7, 8982.CrossRefGoogle ScholarPubMed
Nguyen, LT, Mak, CH, Chen, H et al. (2019) SIRT1 attenuates kidney disorders in male offspring due to maternal high-fat diet. Nutrients 11, 146.CrossRefGoogle ScholarPubMed
Jackson, CM, Alexander, BT, Roach, L et al. (2012) Exposure to maternal overnutrition and a high-fat diet during early postnatal development increases susceptibility to renal and metabolic injury later in life. Am J Physiol Ren Physiol 302, F774F783.CrossRefGoogle Scholar
Flynn, ER, Alexander, BT, Lee, J et al. (2013) High-fat/fructose feeding during prenatal and postnatal development in female rats increases susceptibility to renal and metabolic injury later in life. Am J Physiol Regul Integr Comp Physiol 304, R278R285.CrossRefGoogle ScholarPubMed
Tain, Y-L, Lin, Y-J, Sheen, J-M et al. (2017) High fat diets sex-specifically affect the renal transcriptome and program obesity, kidney injury, and hypertension in the offspring. Nutrients 9, 357.CrossRefGoogle ScholarPubMed
Seneviratne, SN, Jiang, Y, Derraik, JGB et al. (2016) Effects of antenatal exercise in overweight and obese pregnant women on maternal and perinatal outcomes: a randomised controlled trial. BJOG Int J Obstet Gynaecol 123, 588597.CrossRefGoogle ScholarPubMed
Garnæs, KK, Mørkved, S, Salvesen, Ø et al. (2016) Exercise training and weight gain in obese pregnant women: a randomized controlled trial (ETIP trial). PLoS Med 13, e1002079.CrossRefGoogle Scholar
Garnæs, KK, Nyrnes, SA, Salvesen, et al. (2017) Effect of supervised exercise training during pregnancy on neonatal and maternal outcomes among overweight and obese women. Secondary analyses of the ETIP trial: a randomised controlled trial. PLoS ONE 12, e0173937.CrossRefGoogle ScholarPubMed
Nyrnes, SA, Garnæs, KK, Salvesen, Ø et al. (2018) Cardiac function in newborns of obese women and the effect of exercise during pregnancy. A randomized controlled trial. PLoS ONE 13, e0197334.CrossRefGoogle ScholarPubMed
Wang, C, Wei, Y, Zhang, X et al. (2017) A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women. Am J Obstet Gynecol 216, 340351.CrossRefGoogle ScholarPubMed
Bisson, M, Alméras, N, Dufresne, SS et al. (2015) A 12-week exercise program for pregnant women with obesity to improve physical activity levels: an open randomised preliminary study. PLoS ONE 10, e0137742.CrossRefGoogle ScholarPubMed
Santos, IA, Stein, R, Fuchs, SC et al. (2005) Aerobic exercise and submaximal functional capacity in overweight pregnant women: a randomized trial. Obstet Gynecol 106, 243249.CrossRefGoogle ScholarPubMed
Kong, KL, Campbell, C, Wagner, K et al. (2014) Impact of a walking intervention during pregnancy on post-partum weight retention and infant anthropometric outcomes. J Dev Orig Health Dis 5, 259267.CrossRefGoogle ScholarPubMed
Daly, N, Farren, M, McKeating, A et al. (2017) Effect of a randomized controlled trial of an intensive medically supervised exercise program designed to improve maternal glucose control on gestational weight gain. Am J Obstet Gynecol 216, S24.CrossRefGoogle Scholar
Nascimento, S, Surita, F, Parpinelli, M et al. (2011) The effect of an antenatal physical exercise programme on maternal/perinatal outcomes and quality of life in overweight and obese pregnant women: a randomised clinical trial. BJOG Int J Obstet Gynaecol 118, 14551463.CrossRefGoogle ScholarPubMed
Ong, MJ, Guelfi, KJ, Hunter, T et al. (2009) Supervised home-based exercise may attenuate the decline of glucose tolerance in obese pregnant women. Diabetes Metab 35, 418421.CrossRefGoogle ScholarPubMed
Oostdam, N, van Poppel, M, Wouters, M et al. (2012) No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial. BJOG Int J Obstet Gynaecol 119, 10981107.CrossRefGoogle ScholarPubMed
Callaway, LK, Colditz, PB, Byrne, NM et al. (2010) Prevention of gestational diabetes: feasibility issues for an exercise intervention in obese pregnant women. Diabetes Care 33, 14571459.CrossRefGoogle ScholarPubMed
Dekker Nitert, M, Barrett, HL, Denny, KJ et al. (2015) Exercise in pregnancy does not alter gestational weight gain, MCP-1 or leptin in obese women. Aust N Z J Obstet Gynaecol 55, 2733.CrossRefGoogle ScholarPubMed
Mottola, MF, Giroux, I, Gratton, R et al. (2010) Nutrition and exercise prevent excess weight gain in overweight pregnant women. Med Sci Sports Exerc 42, 265272.CrossRefGoogle ScholarPubMed
Dodd, JM, Turnbull, D, McPhee, AJ et al. (2014) Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. Br Med J 348, g1285.CrossRefGoogle ScholarPubMed
Poston, L, Bell, R, Croker, H et al. (2015) Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 3, 767777.CrossRefGoogle ScholarPubMed
Patel, N, Godfrey, KM, Pasupathy, D et al. (2017) Infant adiposity following a randomised controlled trial of a behavioural intervention in obese pregnancy. Int J Obes 2005, 10181026.CrossRefGoogle Scholar
Patel, N, Hellmuth, C, Uhl, O et al. (2017) Cord metabolic profiles in obese pregnant women: insights into offspring growth and body composition. J Clin Endocrinol Metab 103, 346355.CrossRefGoogle Scholar
Mills, HL, Patel, N, White, SL et al. (2019) The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK pregnancies better eating and activity trial (UPBEAT) randomised controlled trial. BMC Med 17, 15.CrossRefGoogle ScholarPubMed
Dalrymple, KV, Tydeman, FAS, Taylor, PD et al. (2021) Adiposity and cardiovascular outcomes in three-year-old children of participants in UPBEAT, an RCT of a complex intervention in pregnant women with obesity. Pediatr Obes 16, e12725.CrossRefGoogle ScholarPubMed
Simmons, D, Devlieger, R, van Assche, A et al. (2017) Effect of physical activity and/or healthy eating on GDM risk: the DALI lifestyle study. J Clin Endocrinol Metab 102, 903913.Google ScholarPubMed
van Poppel, MNM, Simmons, D, Devlieger, R et al. (2019) A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial. Diabetologia 62, 915925.CrossRefGoogle ScholarPubMed
Rönö, K, Grotenfelt, NE, Klemetti, MM et al. (2018) Effect of a lifestyle intervention during pregnancy-findings from the Finnish gestational diabetes prevention trial (RADIEL). J Perinatol 38, 11571164.CrossRefGoogle Scholar
Dieberger, AM, Desoye, G, Stolz, E et al. (2021) Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women – a secondary analysis of the DALI study. Int J Obes 45, 296307.CrossRefGoogle ScholarPubMed
Vinter, CA, Tanvig, MH, Christensen, MH et al. (2018) Lifestyle intervention in Danish obese pregnant women with early gestational diabetes mellitus according to WHO 2013 criteria does not change pregnancy outcomes: results from the LiP (lifestyle in pregnancy) study. Diabetes Care 41, 20792085.CrossRefGoogle Scholar
Vinter, CA, Jensen, DM, Ovesen, P et al. (2011) The LiP (lifestyle in pregnancy) study: a randomized controlled trial of lifestyle intervention in 360 obese pregnant women. Diabetes Care 34, 25022507.CrossRefGoogle ScholarPubMed
Renault, KM, Nørgaard, K, Nilas, L et al. (2014) The treatment of obese pregnant women (TOP) study: a randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women. Am J Obstet Gynecol 210, 134.e1134.e9.CrossRefGoogle ScholarPubMed
Renault, KM, Carlsen, EM, Hædersdal, S et al. (2017) Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers. Int J Obes 41, 598605.CrossRefGoogle ScholarPubMed
Kennelly, MA, Ainscough, K, Lindsay, KL et al. (2018) Pregnancy exercise and nutrition with smartphone application support: a randomized controlled trial. Obstet Gynecol 131, 818826.CrossRefGoogle ScholarPubMed
Brankston, GN, Mitchell, BF, Ryan, EA et al. (2004) Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. Am J Obstet Gynecol 190, 188193.CrossRefGoogle ScholarPubMed
Phelan, S, Phipps, MG, Abrams, B et al. (2011) Randomized trial of a behavioral intervention to prevent excessive gestational weight gain: the fit for delivery study. Am J Clin Nutr 93, 772779.CrossRefGoogle ScholarPubMed
Claesson, I-M, Sydsjö, G, Brynhildsen, J et al. (2008) Weight gain restriction for obese pregnant women: a case-control intervention study. BJOG Int J Obstet Gynaecol 115, 4450.CrossRefGoogle ScholarPubMed
Shirazian, T, Monteith, S, Friedman, F et al. (2010) Lifestyle modification program decreases pregnancy weight gain in obese women. Am J Perinatol 27, 411414.CrossRefGoogle ScholarPubMed
Guelinckx, I, Devlieger, R, Mullie, P et al. (2010) Effect of lifestyle intervention on dietary habits, physical activity, and gestational weight gain in obese pregnant women: a randomized controlled trial. Am J Clin Nutr 91, 373380.CrossRefGoogle ScholarPubMed
Bogaerts, AFL, Devlieger, R, Nuyts, E et al. (2013) Effects of lifestyle intervention in obese pregnant women on gestational weight gain and mental health: a randomized controlled trial. Int J Obes 37, 814821.CrossRefGoogle ScholarPubMed
Harrison, CL, Lombard, CB, Strauss, BJ et al. (2013) Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial. Obesity 21, 904909.CrossRefGoogle ScholarPubMed
Petrella, E, Malavolti, M, Bertarini, V et al. (2014) Gestational weight gain in overweight and obese women enrolled in a healthy lifestyle and eating habits program. J Matern Fetal Neonatal Med 27, 13481352.CrossRefGoogle Scholar
Vega, CC, Reyes-Castro, LA, Bautista, CJ et al. (2015) Exercise in obese female rats has beneficial effects on maternal and male and female offspring metabolism. Int J Obes 2005, 712719.CrossRefGoogle Scholar
Raipuria, M, Bahari, H & Morris, MJ (2015) Effects of maternal diet and exercise during pregnancy on glucose metabolism in skeletal muscle and fat of weanling rats. PLoS ONE 10, e0120980.CrossRefGoogle ScholarPubMed
Boudoures, AL, Chi, M, Thompson, A et al. (2016) The effects of voluntary exercise on oocyte quality in a diet-induced obese murine model. Reproduction 151, 261270.CrossRefGoogle Scholar
Stanford, KI, Lee, M-Y, Getchell, KM et al. (2015) Exercise before and during pregnancy prevents the deleterious effects of maternal high-fat feeding on metabolic health of male offspring. Diabetes 64, 427433.CrossRefGoogle ScholarPubMed
Stanford, KI, Takahashi, H, So, K et al. (2017) Maternal exercise improves glucose tolerance in female offspring. Diabetes 66, 21242136.CrossRefGoogle ScholarPubMed
Laker, RC, Lillard, TS, Okutsu, M et al. (2014) Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1α gene and age-dependent metabolic dysfunction in the offspring. Diabetes 63, 16051611.CrossRefGoogle ScholarPubMed
Laker, RC, Altıntaş, A, Lillard, TS et al. (2021) Exercise during pregnancy mitigates negative effects of parental obesity on metabolic function in adult mouse offspring. J Appl Physiol 130, 605616.CrossRefGoogle ScholarPubMed
Moser, VC, McDaniel, KL, Woolard, EA et al. (2017) Impacts of maternal diet and exercise on offspring behavior and body weights. Neurotoxicol Teratol 63, 4650.CrossRefGoogle ScholarPubMed
Zheng, J, Alves-Wagner, AB, Stanford, KI et al. (2020) Maternal and paternal exercise regulate offspring metabolic health and beta cell phenotype. BMJ Open Diabetes Res Care 8, e000890.CrossRefGoogle ScholarPubMed
Fernandez-Twinn, DS, Gascoin, G, Musial, B et al. (2017) Exercise rescues obese mothers’ insulin sensitivity, placental hypoxia and male offspring insulin sensitivity. Sci Rep 7, 44650.CrossRefGoogle ScholarPubMed
Son, JS, Liu, X, Tian, Q et al. (2019) Exercise prevents the adverse effects of maternal obesity on placental vascularization and fetal growth. J Physiol 597, 33333347.CrossRefGoogle ScholarPubMed
Musial, B, Fernandez-Twinn, DS, Duque-Guimaraes, D et al. (2019) Exercise alters the molecular pathways of insulin signaling and lipid handling in maternal tissues of obese pregnant mice. Physiol Rep 7, e14202.CrossRefGoogle ScholarPubMed
Ribeiro, TA, Tófolo, LP, Martins, IP et al. (2017) Maternal low intensity physical exercise prevents obesity in offspring rats exposed to early overnutrition. Sci Rep 7, 7634.CrossRefGoogle ScholarPubMed
Son, JS, Zhao, L, Chen, Y et al. (2020) Maternal exercise via exerkine apelin enhances brown adipogenesis and prevents metabolic dysfunction in offspring mice. Sci Adv 6, eaaz0359, https://doi.org/10.1126/sciadv.aaz0359.CrossRefGoogle ScholarPubMed
Zhu, X, Ma, Y, Ye, Q et al. (2020) Effects of high-fat diet and exercise intervention on the metabolism regulation of infant mice. BioMed Res Int 2020, 2358391.CrossRefGoogle Scholar
Schoonejans, JM & Ozanne, SE (2021) Developmental programming by maternal obesity: lessons from animal models. Diabet Med 38, e14694.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Summary of the programmed effects of maternal obesity on offspring cardiometabolic health in human subjects and animal models. WAT, white adipose tissue.